{"id":10271,"date":"2024-08-06T16:55:08","date_gmt":"2024-08-06T20:55:08","guid":{"rendered":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/"},"modified":"2026-06-09T15:50:36","modified_gmt":"2026-06-09T19:50:36","slug":"rena-conti","status":"publish","type":"profiles","link":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/","title":{"rendered":"Rena Conti"},"content":{"rendered":"\n<div class=\"wp-block-group alignfull profile__standard-wrapper has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n<div class=\"wp-block-columns profile__columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column profile__left-column is-layout-flow wp-container-core-column-is-layout-3bd72ab2 wp-block-column-is-layout-flow\"><figure class=\"profile__image wp-block-post-featured-image\"><img decoding=\"async\" alt=\"Rena Conti\" style=\"object-fit:contain\" class=\"wp-post-image\" src=\"http:\/\/questromapps.bu.edu\/images\/facstaff\/ContiRena.jpg\" \/><\/figure>\n\n<aside class=\"profile__contact profile__contact--api wp-block-amp-profile-contact\" itemscope itemtype=\"http:\/\/schema.org\/Person\">\n  <h5>Contact<\/h5>\n  <div class=\"profile__contact-row\">\n          <div class=\"profile__contact-cell profile__contact-cell--phone\">\n        <h6 class=\"wp-block-heading has-h-8-font-size\" style=\"font-weight: 500; text-transform: uppercase; margin-top: 0px;\">\n        Phone\n      <\/h6>\n      <p class=\"has-p-2-font-size\" itemprop=\"telephone\">\n        617-353-1156      <\/p>\n    <\/div>\n              <div class=\"profile__contact-cell profile__contact-cell--email\">\n        <h6 class=\"wp-block-heading has-h-8-font-size\" style=\"font-weight: 500; text-transform: uppercase; margin-top: 0px;\">\n        Email\n      <\/h6>\n      <p class=\"has-p-2-font-size\">\n        <a href=\"mailto:rconti@bu.edu\" itemprop=\"email\">\n          rconti@bu.edu        <\/a>\n      <\/p>\n    <\/div>\n          <\/div>\n\n      <div class=\"profile__contact-buttons\">\n              <div class=\"wp-block-button is-style-primary-button\">\n          <a class=\"wp-block-button__link wp-element-button\" href=\"http:\/\/questromapps.bu.edu\/faculty\/uploadFiles\/cvUploadsProfile\/PL_Conti_Rena_CV.pdf\">\n            Download CV\n          <\/a>\n        <\/div>\n                <\/div>\n  \n      <div class=\"profile__contact-row\">\n\n              <div class=\"profile__contact-cell profile__contact-cell--office\">\n          <h6 class=\"wp-block-heading has-h-8-font-size\" style=\"font-weight: 500; text-transform: uppercase; margin-top: 0px;\">\n          Office\n        <\/h6>\n        <p class=\"has-p-2-font-size\" itemprop=\"workLocation\">\n          514B        <\/p>\n      <\/div>\n                    <div class=\"profile__contact-cell profile__contact-cell--bu\">\n          <h6 class=\"wp-block-heading has-h-8-font-size\" style=\"font-weight: 500; text-transform: uppercase; margin-top: 0px\">\n            Boston University <br \/>\n            Questrom School of Business\n          <\/h6>\n                        <p class=\"has-p-2-font-size\" itemprop=\"address\">\n                Rafik B. Hariri Building <br \/>\n                595 Commonwealth Avenue <br \/>\n                Boston, MA 02215\n              <\/p>\n                  <\/div>\n          <\/div>\n  <\/aside><\/div>\n\n\n\n<div class=\"wp-block-column profile__right-column is-layout-flow wp-container-core-column-is-layout-3bd72ab2 wp-block-column-is-layout-flow\">\n<div class=\"wp-block-group profile__header-container has-global-padding is-layout-constrained wp-container-core-group-is-layout-7db9d80f wp-block-group-is-layout-constrained\" style=\"padding-right:0;padding-left:0\">\n<div class=\"wp-block-group profile__header-content has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\"><h1 class=\"wp-block-post-title\">Rena Conti<\/h1>\n\n\n<div class=\"alignfull wp-block-amp-profile-position\">\n\t\t\t<p class=\"has-text-align-left has-text-transform-uppercase has-p-2-font-size\" style=\"text-transform: uppercase; font-weight: 600\">\n\t\t\tProfessor, Markets, Public Policy, and Law\t\t<\/p>\n\t<\/div>\n<\/div>\n<\/div>\n\n\n\n\n\n\n<div class=\"wp-block-amp-profile-data profile-data\">\n\n\n\n<div class=\"wp-block-group profile__data-section has-global-padding is-layout-constrained wp-block-group-is-layout-constrained wp-block-amp-profile-publications\">\n\t<h5 class=\"wp-block-heading\" style=\"font-weight: 500\">\n\tPublications\t<\/h5>\n\n\t<div class=\"wp-block-group profile__data-row has-global-padding is-layout-constrained wp-block-group-is-layout-constrained\">\n\t<p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (In Press). &#8220;Common Agent or Double Agent? Pharmacy Benefit \nManagers in the Prescription Drug Market.&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Minje, P., Carson, A., Erin, F., Conti, R. (In Press). &#8220;Stockpiling Medicines at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices&#8221;, <i>Management Science<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Mattingly, T., Duru, E., Conti, R. (2026). &#8220;Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study.&#8221;, <i>Health Aff Sch<\/i>, <i>4<\/i> (2),  qxag023-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Gong, I., Rafinejad-Farahani, B., Majeed, H., Soto, M., Oza, A., Ehrlich, T., Fernandez Lynch, H., Guerra, C., Lofters, A., Unger, J., Conti, R., Rosenthal, M., Rodin, D. (2026). &#8220;Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.&#8221;, <i>Leuk Lymphoma<\/i>, <i>67<\/i> (1),  176-189<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Gong, I., Soto, M., Rafinejad-Farahani, B., Unger, J., Conti, R., Guerra, C., Oza, A., Rosenthal, M., Rodin, D. (2025). &#8220;Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER-Medicare analysis.&#8221;, <i>Cancer<\/i>, <i>131<\/i> (24),  e70204-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Park, M., Carson, A., Conti, R. (2025). &#8220;Linking Medication Errors to Drug Shortages: Evidence from Heparin Supply Chain Disruptions Caused by Hurricane Maria&#8221;, <i>Manufacturing &amp; Service Operations Management<\/i>, <i>27<\/i> (4),  1008-1024<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., McCue, S., Dockter, T., Gunn, H., Dusetzina, S., Bennett, A., Rapkin, B., Gracia, G., Jazowski, S., Behrens, R., Richardson, P., Chow, S., Subbiah, N., Neuman, H., Chang, G., Weiss, E. (2025). &#8220;Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD).&#8221;, <i>BMJ Open<\/i>, <i>15<\/i> (6),  e091769-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2025). &#8220;The Economics of Generic Drug Shortages.&#8221;, <i>JEP<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., He, S., Conti, R. (2025). &#8220;Changes in Dispensing of Acid Blockers to US Children: 2016\u20132023&#8221;, <i>Pediatrics Open Science<\/i>, <i>1<\/i> (1),  1-10<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Demartino, P., Gruber, J., Lo, A., Sun, Y., Wu, J. (2025). &#8220;Innovative Insurance to Improve US Patient Access to Cell and Gene Therapy.&#8221;, <i>Milbank Q<\/i>, <i>103<\/i> (1),  32-51<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">He, S., Esteban McCabe, S., Conti, R., Volerman, A., Chua, K. (2025). &#8220;Prescription Stimulant Dispensing to US Children: 2017-2023.&#8221;, <i>Pediatrics<\/i>, <i>155<\/i> (2)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R., Becker, N. (2025). &#8220;Mortality in the families of children during the COVID-19 pandemic: evidence from a repeated cross-sectional study of children in the United States.&#8221;, <i>BMC Public Health<\/i>, <i>25<\/i> (1),  376-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Mattingly, T., Conti, R. (2025). &#8220;Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists.&#8221;, <i>JAMA Health Forum<\/i>, <i>6<\/i> (1),  e245015-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Vogel, M., Tellier, A., Conti, R. (2024). &#8220;Predicting the next round of drugs for Medicare price negotiation.&#8221;, <i>Sci Transl Med<\/i>, <i>16<\/i> (776),  eadq5711-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Mcglave, C., Rosenthal, M., Rodin, D. (2024). &#8220;US Trends In Anticancer Medicine Pricing And The Impact Of Competition, 2014-20.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>43<\/i> (12),  1719-1727<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Suleman, A., Santiago, A., Pittman, T., Shapiro, G., Prica, A., Bhella, S., Cole, H., Zeman, K., Rodin, G., Sellmann, S., Oza, A., Jones, J., Conti, R., Rosenthal, M., Rodin, D. (2024). &#8220;Disparities in Clinical Trial Enrollment for Patients with Hematologic Malignancies &#8211; a 15-Year Princess Margaret Cancer Centre Experience&#8221;, <i>Blood<\/i>, <i>144<\/i> (Supplement 1),  401-401<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Gong, I., Rosenthal, M., Soto, M., Rafinejad-Farahani, B., Unger, J., Guerra, C., Conti, R., Rodin, D. (2024). &#8220;Disparities in Clinical Trial Participation Among Medicare Beneficiaries with Hematologic Malignancies from 2006 to 2019: A SEER-Medicare Analysis&#8221;, <i>Blood<\/i>, <i>144<\/i> (Supplement 1),  5113-5113<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Gong, I., Rafinejad-Farahani, B., Majeed, H., Soto, M., Conti, R., Unger, J., Guerra, C., Rosenthal, M., Rodin, D. (2024). &#8220;Disparities in Phase II and III Clinical Trial Enrollment for Hematologic Malignancies&#8221;, <i>Blood<\/i>, <i>144<\/i> (Supplement 1),  5100-5100<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Kirchhoff, A., Waters, A., Liu, Q., Ji, X., Yasui, Y., Yabroff, K., Conti, R., Huang, I., Henderson, T., Leisenring, W., Armstrong, G., Nathan, P., Park, E. (2024). &#8220;Health insurance among survivors of childhood cancer following Affordable Care Act implementation.&#8221;, <i>J Natl Cancer Inst<\/i>, <i>116<\/i> (9),  1466-1478<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R., Lagisetty, P., Bohnert, A., Nuliyalu, U., Nguyen, T. (2024). &#8220;Association Between Cost-Sharing and Buprenorphine Prescription Abandonment.&#8221;, <i>J Gen Intern Med<\/i>, <i>39<\/i> (12),  2160-2168<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Shapiro, G., Santiago, A., Pittman, T., Iwano, K., Rodin, G., Cole, H., Zeman, K., Sellmann, S., Oza, A., Jones, J., Rosenthal, M., Conti, R., Rodin, D. (2024). &#8220;Disparities in clinical trial enrollment at a Canadian comprehensive cancer center: A 15-year retrospective study.&#8221;, <i>Cancer<\/i>, <i>130<\/i> (16),  2782-2794<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R., Lagisetty, P., Bohnert, A., He, S., Nguyen, T. (2024). &#8220;Association Between Cost Sharing and Naloxone Prescription Dispensing.&#8221;, <i>JAMA<\/i>, <i>332<\/i> (2),  124-132<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Levengood, T., Conti, R., Cahill, S., Cole, M. (2024). &#8220;Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature.&#8221;, <i>Milbank Q<\/i>, <i>102<\/i> (2),  429-462<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Wen, K., Harris, D., Chachlani, P., Hayes, K., McCarthy, E., Zullo, A., Smith-Ray, R., Singh, T., Djibo, D., McMahill-Walraven, C., Hiris, J., Conti, R., Gruber, J., Mor, V. (2024). &#8220;COVID-19 Vaccines: Moderna And Pfizer-BioNTech Use Varied By Urban, Rural Counties.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>43<\/i> (5),  659-665<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Frank, R., Cutler, D. (2024). &#8220;The Myth of the Free Market for Pharmaceuticals.&#8221;, <i>N Engl J Med<\/i>, <i>390<\/i> (16),  1448-1450<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Bicket, M., Bohnert, A., Conti, R., Lagisetty, P., Nguyen, T. (2024). &#8220;Buprenorphine Dispensing after Elimination of the Waiver Requirement.&#8221;, <i>N Engl J Med<\/i>, <i>390<\/i> (16),  1530-1532<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Ohlsen, T., Wang, H., Buchbinder, D., Huang, I., Desai, A., Zheng, Z., Kirchhoff, A., Park, E., Krull, K., Conti, R., Yasui, Y., Leisenring, W., Armstrong, G., Yabroff, K., Nathan, P., Chow, E. (2024). &#8220;Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study report.&#8221;, <i>Cancer<\/i>, <i>130<\/i> (7),  1125-1136<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Volerman, A., Zhang, J., Hua, J., Conti, R. (2024). &#8220;Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.&#8221;, <i>Pediatrics<\/i>, <i>153<\/i> (3)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Vogel, M., Kakani, P., Chandra, A., Conti, R. (2024). &#8220;Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act.&#8221;, <i>Nat Biotechnol<\/i>, <i>42<\/i> (3),  406-412<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Waters, A., Liu, Q., Ji, X., Yasui, Y., Yabroff, K., Conti, R., Henderson, T., Huang, I., Leisenring, W., Armstrong, G., Nathan, P., Park, E., Kirchhoff, A. (2024). &#8220;Job lock among survivors of childhood cancer and their spouses post Affordable Care Act implementation: A Childhood Cancer Survivor Study brief report.&#8221;, <i>Pediatr Blood Cancer<\/i>, <i>71<\/i> (2),  e30790-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Lynch, H., Conti, R., Contreras, J. (2024). &#8220;Industry price guarantees for publicly funded medicines: learning from Project NextGen for pandemics and beyond.&#8221;, <i>J Law Biosci<\/i>, <i>11<\/i> (2),  lsae019-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Wong, C., Li, D., Wang, N., Gruber, J., Lo, A., Conti, R. (2023). &#8220;The estimated annual financial impact of gene therapy in the United States.&#8221;, <i>Gene Ther<\/i>, <i>30<\/i> (10-11),  761-773<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Joffe, S., Conti, R., Contreras, J., Largent, E., Lynch, H., Mitchell, D., Sachs, R., Whelan, A., McCoy, M. (2023). &#8220;Access to affordable medicines: obligations of universities and academic medical centers.&#8221;, <i>Gene Ther<\/i>, <i>30<\/i> (10-11),  753-755<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Ohlsen, T., Wang, H., Buchbinder, D., Huang, I., Desai, A., Zheng, Z., Kirchhoff, A., Park, E., Krull, K., Conti, R., Yasui, Y., Leisenring, W., Armstrong, G., Yabroff, R., Nathan, P., Chow, E. (2023). &#8220;Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study (CCSS) report.&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>41<\/i> (16_suppl),  10048-10048<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Shapiro, G., Conti, R., Santiago, A., Pittman, T., Rodin, G., Jones, J., Cole, H., Zeman, K., Sellmann, S., Rosenthal, M., Oza, A., Rodin, D. (2023). &#8220;Disparities in clinical trial enrolment at a Canadian comprehensive cancer centre: A 15-year retrospective study.&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>41<\/i> (16_suppl),  6550-6550<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Nguyen, T., Zhang, J., Conti, R., Lagisetty, P., Bohnert, A. (2023). &#8220;Trends in Buprenorphine Initiation and Retention in the United States, 2016-2022.&#8221;, <i>JAMA<\/i>, <i>329<\/i> (16),  1402-1404<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Hager, A., Gracia, G., Rodin, D., Conti, R. (2023). &#8220;Out-of-Pocket Costs of Treatment Among Employer-Insured Women With Invasive Breast Cancer.&#8221;, <i>JAMA Netw Open<\/i>, <i>6<\/i> (3),  e231507-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Nathan, P., Huang, I., Chen, Y., Henderson, T., Park, E., Kirchhoff, A., Robison, L., Krull, K., Leisenring, W., Armstrong, G., Conti, R., Yasui, Y., Yabroff, K. (2023). &#8220;Financial Hardship in Adult Survivors of Childhood Cancer in the Era After Implementation of the Affordable Care Act: A Report From the Childhood Cancer Survivor Study.&#8221;, <i>J Clin Oncol<\/i>, <i>41<\/i> (5),  1000-1010<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Becker, N., Seelye, S., Chua, K., Echevarria, K., Conti, R., Prescott, H. (2023). &#8220;Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic.&#8221;, <i>JAMA Netw Open<\/i>, <i>6<\/i> (2),  e2254859-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R. (2023). &#8220;Out-of-Pocket Spending on Epinephrine Auto-Injectors Among the Privately Insured, 2015-2019.&#8221;, <i>J Gen Intern Med<\/i>, <i>38<\/i> (2),  538-541<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Akesson, J., Weiss, E., Sae-Hau, M., Gracia, G., Lee, M., Culp, L., Connell, B., Butterfield, S., Conti, R. (2023). &#8220;COVID-19 Vaccine-Related Beliefs and Behaviors Among Patients With and Survivors of Hematologic Malignancies.&#8221;, <i>JCO Oncol Pract<\/i>, <i>19<\/i> (2),  e167-e175<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Park, M., Carson, A., Conti, R. (2023). &#8220;Linking Medication Errors to Supply Chain Disruptions: Evidence from Heparin Shortages Caused by Hurricane Maria&#8221;, <i>SSRN Electronic Journal<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Auty, S., Griffith, K., Shafer, P., Gee, R., Conti, R. (2022). &#8220;Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States.&#8221;, <i>J Health Polit Policy Law<\/i>, <i>47<\/i> (6),  691-708<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Frank, R., Conti, R., Gruber, J. (2022). &#8220;International Reference Pricing in the Context of US Drug Policy.&#8221;, <i>J Health Polit Policy Law<\/i>, <i>47<\/i> (6),  779-796<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Levengood, T., Aronsohn, A., Chua, K., Conti, R. (2022). &#8220;Dispensing of HIV and Hepatitis C Antivirals During COVID-19: An Interrupted Time-Series Analysis of U.S. National Data.&#8221;, <i>Am J Prev Med<\/i>, <i>63<\/i> (4),  532-542<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Smith, G., Banegas, M., Acquati, C., Chang, S., Chino, F., Conti, R., Greenup, R., Kroll, J., Liang, M., Pisu, M., Primm, K., Roth, M., Shankaran, V., Yabroff, K. (2022). &#8220;Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.&#8221;, <i>CA Cancer J Clin<\/i>, <i>72<\/i> (5),  437-453<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Corrigan, K., Fu, S., Chen, Y., Kaiser, K., Roth, M., Peterson, S., Shih, Y., Jagsi, R., Giordano, S., Volk, R., Yabroff, K., Banegas, M., Acquati, C., Conti, R., Ma, H., Ku, K., You, Y., Smith, G. (2022). &#8220;Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery.&#8221;, <i>Cancer<\/i>, <i>128<\/i> (13),  2455-2462<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Rodin, D., Rosenthal, M., McGlave, C., Bhaskar, A., To, C., Conti, R. (2022). &#8220;National trends in post-launch cancer prescription drug prices and the impact of generic entry, 2014-2020.&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>40<\/i> (16_suppl),  6598-6598<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Rodin, D., Rosenthal, M., McGlave, C., Bhaskar, A., To, C., Conti, R. (2022). &#8220;National trends in post-launch cancer prescription drug prices and the impact of generic entry, 2014-2020.&#8221;, <i>JOURNAL OF CLINICAL ONCOLOGY<\/i>, <i>40<\/i> (16)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., McCue, S., Dockter, T., Dusetzina, S., Rapkin, B., Weiss, E., Behrens, R., Richardson, P. (2022). &#8220;Self-reported financial difficulties among patients with multiple myeloma and chronic lymphocytic leukemia: An Alliance for Clinical Trials in Oncology study.&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>40<\/i> (16_suppl),  6602-6602<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Mattingly, T., Conti, R. (2022). &#8220;Ensuring a high-quality and resilient supply chain of essential medications means paying more.&#8221;, <i>J Manag Care Spec Pharm<\/i>, <i>28<\/i> (5),  573-576<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Volerman, A., Pelczar, A., Conti, R., Ciaccio, C., Chua, K. (2022). &#8220;Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists.&#8221;, <i>BMC Health Serv Res<\/i>, <i>22<\/i> (1),  562-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Dahlem, C., Nguyen, T., Brummett, C., Conti, R., Bohnert, A., Dora-Laskey, A., Kocher, K. (2022). &#8220;Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.&#8221;, <i>Ann Emerg Med<\/i>, <i>79<\/i> (3),  225-236<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R., Becker, N. (2022). &#8220;US Insurer Spending on Ivermectin Prescriptions for COVID-19.&#8221;, <i>JAMA<\/i>, <i>327<\/i> (6),  584-587<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R., Becker, N. (2022). &#8220;Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021.&#8221;, <i>JAMA Netw Open<\/i>, <i>5<\/i> (2),  e2148237-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Fendrick, A., Conti, R., Moniz, M. (2022). &#8220;Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured&#8221;, <i>Obstetrical &amp; Gynecological Survey<\/i>, <i>77<\/i> (1),  11-13<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Killelea, A., Johnson, J., Dangerfield, D., Beyrer, C., McGough, M., McIntyre, J., Gee, R., Ballreich, J., Conti, R., Horn, T., Pickett, J., Sharfstein, J. (2022). &#8220;Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic.&#8221;, <i>J Law Med Ethics<\/i>, <i>50<\/i> (S1),  8-23<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Ballreich, J., Levengood, T., Conti, R. (2022). &#8220;Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV.&#8221;, <i>J Law Med Ethics<\/i>, <i>50<\/i> (S1),  32-39<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Sharfstein, J., Conti, R., Gee, R. (2022). &#8220;From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public&#8217;s Health.&#8221;, <i>J Law Med Ethics<\/i>, <i>50<\/i> (S1),  29-31<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Frank, R., Nichols, L. (2021). &#8220;How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?&#8221;, <i>JAMA Health Forum<\/i>, <i>2<\/i> (12),  e214242-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Maldonado, J., Fu, S., Chen, Y., Acquati, C., Yabroff, K., Banegas, M., Chang, S., Conti, R., Checka, C., Peterson, S., Advani, P., Ku, K., Jagsi, R., Giordano, S., Volk, R., Shih, Y., Smith, G. (2021). &#8220;Sensitivity of Psychosocial Distress Screening to Identify Cancer Patients at Risk for Financial Hardship During Care Delivery.&#8221;, <i>JCO Oncol Pract<\/i>, <i>17<\/i> (12),  e1856-e1865<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Frank, R., Gruber, J. (2021). &#8220;Regulating Drug Prices while Increasing Innovation.&#8221;, <i>N Engl J Med<\/i>, <i>385<\/i> (21),  1921-1923<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R. (2021). &#8220;Prescriptions for Codeine or Hydrocodone Cough and Cold Medications to US Children and Adolescents Following US Food and Drug Administration Safety Communications.&#8221;, <i>JAMA Netw Open<\/i>, <i>4<\/i> (11),  e2134142-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R., Becker, N. (2021). &#8220;Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020.&#8221;, <i>JAMA Netw Open<\/i>, <i>4<\/i> (10),  e2129894-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Brummett, C., Conti, R., Bohnert, A. (2021). &#8220;Opioid Prescribing to US Children and Young Adults in 2019.&#8221;, <i>Pediatrics<\/i>, <i>148<\/i> (3)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Volerman, A., Conti, R. (2021). &#8220;Prescription Drug Dispensing to US Children During the COVID-19 Pandemic.&#8221;, <i>Pediatrics<\/i>, <i>148<\/i> (2)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Mattingly, T., Seo, D., Ostrovsky, A., Vanness, D., Conti, R. (2021). &#8220;60\u00a0Years after Kefauver: Household income required to buy prescription drugs in the United States and abroad.&#8221;, <i>Res Social Adm Pharm<\/i>, <i>17<\/i> (8),  1489-1495<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Padula, W., Becker, R., Salamone, S. (2021). &#8220;The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia.&#8221;, <i>J Manag Care Spec Pharm<\/i>, <i>27<\/i> (8),  1077-1085<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Fendrick, A., Conti, R., Moniz, M. (2021). &#8220;Prevalence and Magnitude of Potential Surprise Bills for Childbirth.&#8221;, <i>JAMA Health Forum<\/i>, <i>2<\/i> (7),  e211460-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Fendrick, A., Conti, R., Moniz, M. (2021). &#8220;Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured.&#8221;, <i>Pediatrics<\/i>, <i>148<\/i> (1)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., McCue, S., Dockter, T., Rapkin, B., Dusetzina, S., Bennett, A., Gracia, G., Johnson, M., Martin, S., Chang, G., Richardson, P., Behrens, R., Weiss, E. (2021). &#8220;Assessing financial difficulty in patients with multiple myeloma: Preliminary results of ALLIANCE A231602CD.&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>39<\/i> (15_suppl),  8031-8031<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Nathan, P., Huang, I., Chen, Y., Henderson, T., Park, E., Kirchhoff, A., Robison, L., Krull, K., Armstrong, G., Leisenring, W., Conti, R., Yasui, Y., Yabroff, R. (2021). &#8220;Financial hardship in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>39<\/i> (15_suppl),  10026-10026<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Lo, A., Wong, C., Gruber, J. (2021). &#8220;Estimating the Financial Impact of Gene Therapy in the U.S.&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R. (2021). &#8220;Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage.&#8221;, <i>Am J Prev Med<\/i>, <i>60<\/i> (4),  537-541<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Kimmel, L., Conti, R. (2021). &#8220;Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>40<\/i> (3),  453-460<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Turner, A., Hughes-Cromwick, P. (2021). &#8220;Projections of US Prescription Drug Spending and Key Policy Implications.&#8221;, <i>JAMA Health Forum<\/i>, <i>2<\/i> (1),  e201613-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Lee, J., Conti, R. (2021). &#8220;Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients With Type 1 Diabetes.&#8221;, <i>JAMA Pediatr<\/i>, <i>175<\/i> (1),  90-92<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Padula, W., Parasrampuria, S., Socal, M., Conti, R., Anderson, G. (2020). &#8220;Reply to Comment on &#8220;Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US&#8221;.&#8221;, <i>Pharmacoeconomics<\/i>, <i>38<\/i> (12),  1375-1376<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R. (2020). &#8220;Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.&#8221;, <i>JAMA Intern Med<\/i>, <i>180<\/i> (10),  1273-1274<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Padula, W., Parasrampuria, S., Socal, M., Conti, R., Anderson, G. (2020). &#8220;Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US.&#8221;, <i>Pharmacoeconomics<\/i>, <i>38<\/i> (10),  1115-1121<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R. (2020). &#8220;Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013-18.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>39<\/i> (10),  1806-1811<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Lee, J., Conti, R. (2020). &#8220;Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes.&#8221;, <i>JAMA Intern Med<\/i>, <i>180<\/i> (7),  1012-1014<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Kimmel, L., Conti, R., Volerman, A., Chua, K. (2020). &#8220;Pediatric Orphan Drug Indications: 2010-2018.&#8221;, <i>Pediatrics<\/i>, <i>145<\/i> (4)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Nikpay, S., Buntin, M., Conti, R. (2020). &#8220;Relationship between initiation of 340B participation and hospital safety-net engagement.&#8221;, <i>Health Serv Res<\/i>, <i>55<\/i> (2),  157-169<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Dusetzina, S., Sachs, R. (2020). &#8220;How The ACA Reframed The Prescription Drug Market And Set The Stage For Current Reform Efforts.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>39<\/i> (3),  445-452<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Brummett, C., Conti, R., Bohnert, A. (2020). &#8220;Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young Adults.&#8221;, <i>JAMA Pediatr<\/i>, <i>174<\/i> (2),  141-148<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Schwartz, A., Volerman, A., Conti, R., Huang, E. (2020). &#8220;Differences in the Receipt of Low-Value Services Between Publicly and Privately Insured Children.&#8221;, <i>Pediatrics<\/i>, <i>145<\/i> (2)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Fox, E., Conti, R. (2020). &#8220;<i>Pharmacy Forecast<\/i> 2020: Pharmaceutical Supply Chain&#8221;, <i>AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY<\/i>, <i>77<\/i> (2),  101-103<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Vermeulen, L., Swarthout, M., Alexander, G., Ginsburg, D., Pritchett, K., White, S., Tryon, J., Emmerich, C., Nesbit, T., Greene, W., Fox, E., Conti, R., Scott, B., Sheehy, F., Melby, M., Lantzy, M., Hoffman, J., Knoer, S., Zellmer, W. (2020). &#8220;ASHP Foundation Pharmacy Forecast 2020: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems.&#8221;, <i>Am J Health Syst Pharm<\/i>, <i>77<\/i> (2),  84-112<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., David, F. (2020). &#8220;Public research funding and pharmaceutical prices: do Americans pay twice for drugs?&#8221;, <i>F1000Res<\/i>, <i>9<\/i> 707-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Woo, J., Anderson, B., Gruenstein, D., Conti, R., Chua, K. (2019). &#8220;Minimum Travel Distance Among Publicly Insured Infants with Severe Congenital Heart Disease: Potential Impact of In-state Restrictions.&#8221;, <i>Pediatr Cardiol<\/i>, <i>40<\/i> (8),  1599-1608<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chen, A., Hu, X., Conti, R., Jena, A., Goldman, D. (2019). &#8220;Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017.&#8221;, <i>Value Health<\/i>, <i>22<\/i> (12),  1387-1395<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Berndt, E., Shivdasani, Y., Kaygisiz, N. (2019). &#8220;The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2019). &#8220;Financial Toxicity of Prescription Drugs.&#8221;, <i>Ann Intern Med<\/i>, <i>171<\/i> (9),  665-666<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Berndt, E., Adajar, P. (2019). &#8220;The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Nikpay, S., Buntin, M. (2019). &#8220;Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016&#8221;, <i>JAMA Network Open<\/i>, <i>2<\/i> (10),  e1914141-e1914141<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2019). &#8220;3 Things You Need to Know About Prescription Drug Affordability&#8221;, <i>Institute for Health System Innovation &#038; Policy<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2019). &#8220;The Orphan Drug Act: IHSIP Expertise in Policy Action&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Berndt, E. (2019). &#8220;Four Facts Concerning Competition in US Generic Prescription Drug Markets&#8221;, <i>International Journal of the Economics of Business<\/i> 1-22<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Berndt, E. (2019). &#8220;Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Kleutghen, P. (2019). &#8220;Is \u2018Competitive Licensing\u2019 Proposed In HR 1046 Practical For Lowering Drug Prices?&#8221;, <i>Health Affairs<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Chua, K. (2019). &#8220;Orphan Drugs For Opioid Use Disorder: An Abuse Of The Orphan Drug Act&#8221;, <i>Health Affairs<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Royce, T., Kircher, S., Conti, R. (2019). &#8220;Pharmacy Benefit Manager Reform&#8221;, <i>JAMA<\/i>, <i>322<\/i> (4),  299-299<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., David, F. (2019). &#8220;Rebalancing High Prescription Drug Prices With Innovation Incentives&#8221;, <i>Health Affairs<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Brummett, C., Conti, R., Haffajee, R., Prosser, L., Bohnert, A. (2019). &#8220;Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids&#8221;, <i>JAMA Network Open<\/i>, <i>2<\/i> (5),  e193673-e193673<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R. (2019). &#8220;Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014&#8221;, <i>Journal of General Internal Medicine<\/i>, <i>34<\/i> (3),  338-340<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">GaBI Journal Editor, . (2018). &#8220;US generic prescription drug markets 2004\u20132016&#8221;, <i>Generics and Biosimilars Initiative Journal<\/i>, <i>7<\/i> (4),  164-164<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Parsons, S., Castellino, S., Rodday, A., Keller, F., Kelly, K., Conti, R., Lerner, D., Henderson, T. (2018). &#8220;Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)&#8221;, <i>Blood<\/i>, <i>132<\/i> (Supplement 1),  975-975<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Nikpay, S., Buntin, M. (2018). &#8220;Diversity of Participants in the 340B Drug Pricing Program for US Hospitals&#8221;, <i>Journal of the American Medical Association Internal Medicine<\/i>, <i>178<\/i> (8),  1124-1127<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Nguyen, K., Rosenthal, M. (2018). &#8220;Generic Prescription Drug Price Increases: Which Products Will Be Affected by Proposed Anti-Gouging Legislation&#8221;, <i>Journal of Pharmaceutical Policy and Practice<\/i>, <i>11<\/i> (1),  29-29<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Chua, K. (2018). &#8220;Out-of-Pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014&#8221;, <i>Journal of General Internal Medicine<\/i>, <i>178<\/i> (4),  133-140<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\"> (2018). &#8220;AMCP Partnership Forum: Driving Value and Outcomes in Oncology.&#8221;, <i>J Manag Care Spec Pharm<\/i>, <i>24<\/i> (6),  572-578<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Parsons, S., Lerner, D., Rodday, A., Curtis, R., Kelly, K., Conti, R., Castellino, S., Henderson, T. (2018). &#8220;Parental work limitations at diagnosis of advanced stage pediatric Hodgkin lymphoma\u2014Results of caregiver work limitations questionnaire (CG WLQ).&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>36<\/i> (15_suppl),  e18927-e18927<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Berndt, E., Conti, R., Murphy, S. (2018). &#8220;The generic drug user fee amendments: an economic perspective&#8221;, <i>Journal of Law and the Biosciences<\/i>, <i>5<\/i> (1),  103-141<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Aggarwal, M., Devries, S., Freeman, A., Ostfeld, R., Gaggin, H., Taub, P., Rzeszut, A., Allen, K., Conti, R. (2018). &#8220;The Deficit of Nutrition Education of Physicians.&#8221;, <i>Am J Med<\/i>, <i>131<\/i> (4),  339-345<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Berndt, E. (2018). Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001\u20132007. In David, Cutler. (Eds.), &#8220;Measuring and Modeling Health Care Costs\nAdvances in CRIW Conference Proceedings&#8221;, <i>University of Chicago Press<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Chua, K., Shrime, M. (2017). &#8220;Effect of FDA Investigation on Opioid Prescribing to Children after Tonsillectomy\/Adenoidectomy&#8221;, <i>Pediatrics<\/i>, <i>140<\/i> (6),  6-6<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2017). &#8220;Making Medicines Affordable: A National Imperative \u2014 A Review&#8221;, <i>Health Affairs<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Nikpay, S., Buntin, M. (2017). &#8220;The 340B Program: Mandatory Reporting, Alternative Eligibility Criteria Should Be Top Priorities for Congress&#8221;, <i>Health Affairs<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dusetzina, S., Conti, R., Yu, N., Bach, P. (2017). &#8220;Association of Prescription Drug Price Rebates in Medicare Part D with Patient Out-of-Pocket and Federal Spending&#8221;, <i>Journal of the American Medical Association Internal Medicine<\/i>, <i>177<\/i> (8),  1185-1188<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2017). &#8220;Biosimilars: Reimbursement Issues in Your Oncology Practice&#8221;, <i>Journal of Oncology Practice<\/i>, <i>13<\/i> (9),  12-14<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., DeSouza, J. (2017). &#8220;Mitigating Financial Toxicity among US Patients with Cancer&#8221;, <i>Journal of the American Medical Association Oncology<\/i>, <i>3<\/i> (6),  765-766<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2017). &#8220;Biosimilars: Reimbursement Issues in Your Oncology Practice.&#8221;, <i>Journal of oncology practice<\/i>, <i>13<\/i> (9_suppl),  12s-14s<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Berndt, E. (2017). &#8220;The Generic Drug User Fee Amendments: An Economic Perspective&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Murphy, S., Berndt, E. (2017). &#8220;The Landscape of US Generic Prescription Drug Markets, 2004\u20132016&#8221;, <i>The National Bureau of Economic Research<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Chua, K. (2017). &#8220;Out-of-Pocket Spending among Commercially Insured Patients for Epinephrine Autoinjectors between 2007 and 2014&#8221;, <i>Journal of the American Medical Association Internal Medicine<\/i>, <i>176<\/i> (2),  736-739<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R. (2017). &#8220;Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014.&#8221;, <i>JAMA Intern Med<\/i>, <i>177<\/i> (5),  736-739<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Jones, D. (2017). &#8220;Policy Diffusion across Disparate Disciplines: Private- and Public-Sector Dynamics Affecting State-Level Adoption of the ACA&#8221;, <i>Journal of Health Politics, Policy and Law<\/i>, <i>42<\/i> (2),  377-385<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Conti, R., Freed, G. (2017). &#8220;Appropriately Framing Child Health Care Spending: A Prerequisite for Value Improvement&#8221;, <\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., padula, w. (2017). Changing the Cost of Care for Chronic Myeloid Leukemia: The Availability of Generic Imatinib in the U.S. and the E.U.. In Richard, Hehlmann. (Eds.), &#8220;Chronic Myeloid Leukemia: What Every Clinical Practitioner Needs to Know in 2017&#8221;, <i>ASCO<\/i><\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dragoni, F., Conti, R., Cazzaniga, S., Colucci, R., Pisaneschi, L., Naldi, L., Moretti, S. (2017). &#8220;No Association between Vitiligo and Obesity: A Case-Control Study.&#8221;, <i>Med Princ Pract<\/i>, <i>26<\/i> (5),  421-426<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Henderson, T., Castellino, S., Keller, F., Kelly, K., Curtis, R., Conti, R., Parsons, S. (2016). &#8220;Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Children and Adolescents&#8221;, <i>Blood<\/i>, <i>128<\/i> (22),  3583-3583<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Darlington, W., Watson, S., Henderson, T., Cunningham, J., Conti, R. (2016). &#8220;The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell Disease&#8221;, <i>Blood<\/i>, <i>128<\/i> (22),  4747-4747<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chua, K., Schwartz, A., Volerman, A., Conti, R., Huang, E. (2016). &#8220;Use of Low-Value Pediatric Services Among the Commercially Insured&#8221;, <i>PEDIATRICS<\/i>, <i>138<\/i> (6),  e20161809-e20161809<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Gee, R., Sharfstein, J. (2016). &#8220;Pharmaceuticals and Public Health.&#8221;, <i>JAMA<\/i>, <i>316<\/i> (20),  2083-2084<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Pitts, P., Louet, H., Moride, Y., Conti, R. (2016). &#8220;21st century pharmacovigilance: efforts, roles, and responsibilities.&#8221;, <i>Lancet Oncol<\/i>, <i>17<\/i> (11),  e486-e492<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Castellino, S., Henderson, T., Keller, F., Kelly, K., Curtis, R., Conti, R., Parsons, S. (2016). &#8220;APPROACH AND FEASIBILITY OF PATIENT-REPORTED OUTCOMES IN A PHASE III CLINICAL TRIAL FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS&#8221;, <i>HAEMATOLOGICA<\/i>, <i>101<\/i> 37-37<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2016). &#8220;The Advantages of Awarding the Federal Government Negotiating Power Over the Prices of Prescription Drugs&#8221;, <i>Journal of Policy Analysis and Management<\/i>, <i>35<\/i> (4),  964-970<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2016). &#8220;Response to Joyce and Sood&#8221;, <i>Journal of Policy Analysis and Management<\/i>, <i>35<\/i> (4),  972-974<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Padula, W., Larson, R., Dusetzina, S., Apperley, J., Hehlmann, R., Baccarani, M., Eigendorff, E., Guilhot, J., Guilhot, F., Hehlmann, R., Mahon, F., Martinelli, G., Mayer, J., M\u00fcller, M., Niederwieser, D., Saussele, S., Schiffer, C., Silver, R., Simonsson, B., Conti, R. (2016). &#8220;Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.&#8221;, <i>J Natl Cancer Inst<\/i>, <i>108<\/i> (7)<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Polite, B., Ward, J., Cox, J., Morton, R., Hennessy, J., Page, R., Conti, R. (2016). &#8220;A Pathway Through the Bundle Jungle.&#8221;, <i>J Oncol Pract<\/i>, <i>12<\/i> (6),  504-509<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Weiner, A., Conti, R., Eggener, S. (2016). &#8220;National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management Decisions.&#8221;, <i>J Urol<\/i>, <i>195<\/i> (5),  1383-1389<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Clark, B., Hou, J., Huang, E., Conti, R., Chou, C. (2016). &#8220;Medication Adherence among Hiv\/Aids Patients Receiving 340b-Purchased Antiretroviral Medications&#8221;, <i>Value in Health<\/i>, <i>19<\/i> (3),  A8-A8<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Bach, P., Conti, R., Muller, R., Schnorr, G., Saltz, L. (2016). &#8220;Overspending driven by oversized single dose vials of cancer drugs.&#8221;, <i>BMJ<\/i>, <i>352<\/i> i788-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Rosenthal, M. (2016). &#8220;Pharmaceutical Policy Reform&#8211;Balancing Affordability with Incentives for Innovation.&#8221;, <i>N Engl J Med<\/i>, <i>374<\/i> (8),  703-706<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dusetzina, S., Ellis, S., Freedman, R., Conti, R., Winn, A., Chambers, J., Alexander, G., Huskamp, H., Keating, N. (2015). &#8220;How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab.&#8221;, <i>J Oncol Pract<\/i>, <i>11<\/i> (4),  313-318<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Padula, W., Larson, R., Conti, R., Dusetzina, S. (2015). &#8220;Comparing tyrosine kinase inhibitor treatment strategies for newly diagnosed chronic myeloid leukemia in chronic phase when imatinib loses patent exclusivity in the u.s.: a cost-effectiveness analysis&#8221;, <i>Value in Health<\/i>, <i>18<\/i> (3),  A205-A205<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Polite, B., Ward, J., Cox, J., Morton, R., Hennessy, J., Page, R., Conti, R. (2015). &#8220;Reply to M. Thompson et Al.&#8221;, <i>J Oncol Pract<\/i>, <i>11<\/i> (3),  263-264<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Padula, W., Larson, R. (2015). &#8220;Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU.&#8221;, <i>Ann Hematol<\/i>, <i>94 Suppl 2<\/i> (0 2),  S249-S257<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Gibbons, R., Coca Perraillon, M., Hur, K., Conti, R., Valuck, R., Brent, D. (2015). &#8220;Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.&#8221;, <i>Pharmacoepidemiol Drug Saf<\/i>, <i>24<\/i> (2),  208-214<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2015). &#8220;Expanding the Scope of the National Practice Oncology Benchmark Would Be a Critical Source for Understanding Outpatient Oncology Practice Costs and Profits in a Time of Change.&#8221;, <i>J Oncol Pract<\/i>, <i>11<\/i> (1),  e95-e97<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Polite, B., Conti, R., Ward, J. (2015). &#8220;Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.&#8221;, <i>Am Soc Clin Oncol Educ Book<\/i> e75-e80<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Howard, D., Bach, P., Berndt, E., Conti, R. (2015). &#8220;Pricing in the Market for Anticancer Drugs.&#8221;, <i>J Econ Perspect<\/i>, <i>29<\/i> (1),  139-162<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Larson, R., Conti, R., Padula, W., Apperley, J., Baccarani, M., Eigendorff, E., Guilhot, F., Guilhot, J., Mahon, F., Martinelli, G., Mayer, J., Mueller, M., Niederwieser, D., Saussele, S., Schiffer, C., Silver, R., Simonsson, B., Hehlmann, R. (2014). &#8220;What Is the Most Cost-Effective Strategy for Treating Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) after Imatinib Loses Patent Exclusivity?&#8221;, <i>Blood<\/i>, <i>124<\/i> (21),  738-738<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Polite, B., Ward, J., Cox, J., Morton, R., Hennessy, J., Page, R., Conti, R. (2014). &#8220;Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.&#8221;, <i>J Oncol Pract<\/i>, <i>10<\/i> (6),  357-362<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Bach, P. (2014). &#8220;Improving outpatient oncology practice: several steps into a long journey.&#8221;, <i>J Oncol Pract<\/i>, <i>10<\/i> (6),  355-356<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Clark, B., Hou, J., Chou, C., Huang, E., Conti, R. (2014). &#8220;The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>33<\/i> (11),  2012-2017<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Padula, W., Conti, R., Larson, R. (2014). &#8220;What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?&#8221;, <i>Value Health<\/i>, <i>17<\/i> (7),  A636-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dusetzina, S., Winn, A., Chambers, J., Ellis, S., Conti, R., Freedman, R., Alexander, G., Keating, N., Huskamp, H. (2014). &#8220;Payer-Level Differences in the Response to Regulatory Actions Regarding Withdrawal of Breast Cancer as an Indication for Bevacizumab&#8221;, <i>JOURNAL OF WOMENS HEALTH<\/i>, <i>23<\/i> (10),  857-857<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Fein, A., Bhatta, S. (2014). &#8220;National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>33<\/i> (10),  1721-1727<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Bach, P. (2014). &#8220;The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>33<\/i> (10),  1786-1792<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Howard, D., Conti, R. (2014). &#8220;Are new drugs more expensive than old ones? Trends in the benefit-adjusted launch prices of anticancer drugs, 1995-2013.&#8221;, <i>Journal of Clinical Oncology<\/i>, <i>32<\/i> (15_suppl),  6525-6525<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Goldberg, P., Conti, R. (2014). &#8220;Problems with public reporting of cancer quality outcomes data.&#8221;, <i>J Oncol Pract<\/i>, <i>10<\/i> (3),  215-218<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2013). &#8220;Drug discount program&#8211;reply.&#8221;, <i>JAMA<\/i>, <i>310<\/i> (15),  1627-<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Dusetzina, S., Herbert, A., Berndt, E., Huskamp, H., Keating, N. (2013). &#8220;The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer.&#8221;, <i>Med Care<\/i>, <i>51<\/i> (7),  622-627<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Bach, P. (2013). &#8220;Cost consequences of the 340B drug discount program.&#8221;, <i>JAMA<\/i>, <i>309<\/i> (19),  1995-1996<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Kornfield, R., Watson, S., Higashi, A., Conti, R., Dusetzina, S., Garfield, C., Dorsey, E., Huskamp, H., Alexander, G. (2013). &#8220;Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.&#8221;, <i>Psychiatr Serv<\/i>, <i>64<\/i> (4),  339-346<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Bernstein, A., Villaflor, V., Schilsky, R., Rosenthal, M., Bach, P. (2013). &#8220;Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.&#8221;, <i>J Clin Oncol<\/i>, <i>31<\/i> (9),  1134-1139<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Bhatta, S., Fein, A., Conti, R. (2013). &#8220;TRENDS IN SPENDING ON ORAL CHEMOTHERAPEUTIC AGENTS 2006-2012&#8221;, <i>CLINICAL PHARMACOLOGY &#038; THERAPEUTICS<\/i>, <i>93<\/i> S12-S12<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dusetzina, S., Busch, A., Conti, R., Donohue, J., Alexander, G., Huskamp, H. (2012). &#8220;Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory.&#8221;, <i>Pharmacoepidemiol Drug Saf<\/i>, <i>21<\/i> (12),  1251-1260<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dusetzina, S., Higashi, A., Dorsey, E., Conti, R., Huskamp, H., Zhu, S., Garfield, C., Alexander, G. (2012). &#8220;Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.&#8221;, <i>Med Care<\/i>, <i>50<\/i> (6),  466-478<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Rosenthal, M., Polite, B., Bach, P., Shih, Y. (2012). &#8220;Infused chemotherapy use in the elderly after patent expiration.&#8221;, <i>Am J Manag Care<\/i>, <i>18<\/i> (5),  e173-e178<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Rosenthal, M., Polite, B., Bach, P., Shih, Y. (2012). &#8220;Infused chemotherapy use in the elderly after patent expiration.&#8221;, <i>J Oncol Pract<\/i>, <i>8<\/i> (3 Suppl),  e18s-e23s<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Philipson, T., Eber, M., Lakdawalla, D., Corral, M., Conti, R., Goldman, D. (2012). &#8220;An analysis of whether higher health care spending in the United States versus Europe is &#8216;worth it&#8217; in the case of cancer.&#8221;, <i>Health Aff (Millwood)<\/i>, <i>31<\/i> (4),  667-675<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Pillarella, J., Higashi, A., Alexander, G., Conti, R. (2012). &#8220;Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009.&#8221;, <i>Psychiatr Serv<\/i>, <i>63<\/i> (1),  83-86<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Garfield, C., Dorsey, E., Zhu, S., Huskamp, H., Conti, R., Dusetzina, S., Higashi, A., Perrin, J., Kornfield, R., Alexander, G. (2012). &#8220;Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.&#8221;, <i>Acad Pediatr<\/i>, <i>12<\/i> (2),  110-116<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Bernstein, A., Meltzer, D. (2012). &#8220;How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatments.&#8221;, <i>Adv Health Econ Health Serv Res<\/i>, <i>23<\/i> 123-148<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dusetzina, S., Alexander, G., Conti, R., Dorsey, E., Higashi, A., Zhu, S., Garfield, C., Huskamp, H. (2011). &#8220;Predictors of High Metabolic Risk Antipsychotic Use&#8221;, <i>PHARMACOEPIDEMIOLOGY AND DRUG SAFETY<\/i>, <i>20<\/i> S264-S264<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Garfield, C., Dorsey, E., Zhu, S., Higashi, A., Huskamp, H., Conti, R., Dusetzina, S., Alexander, G. (2011). &#8220;US Trends in the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, 2000-2010&#8221;, <i>PHARMACOEPIDEMIOLOGY AND DRUG SAFETY<\/i>, <i>20<\/i> S197-S197<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2011). &#8220;Overuse of Antidepressants in a Nationally Representative Adult Patient Population in 2005&#8221;, <i>Psychiatric Services<\/i>, <i>62<\/i> (7),  720-720<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Busch, A., Cutler, D. (2011). &#8220;Overuse of antidepressants in a nationally representative adult patient population in 2005.&#8221;, <i>Psychiatr Serv<\/i>, <i>62<\/i> (7),  720-726<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Alexander, G., Garfield, C., Dorsey, R., Zhu, S., Higashi, A., Huskamp, H., Conti, R., Dusetzina, S. (2011). &#8220;US TRENDS IN THE DIAGNOSIS AND TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER, 2000-2010&#8221;, <i>JOURNAL OF GENERAL INTERNAL MEDICINE<\/i>, <i>26<\/i> S253-S253<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Qato, D., Lindau, S., Conti, R., Schumm, L., Alexander, G. (2010). &#8220;Racial and ethnic disparities in cardiovascular medication use among older adults in the United States.&#8221;, <i>Pharmacoepidemiol Drug Saf<\/i>, <i>19<\/i> (8),  834-842<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2010). &#8220;Advances in economics to further inform investments in vaccine development&#8221;, <i>Human Vaccines<\/i>, <i>6<\/i> (4),  286-291<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2010). &#8220;Advances in economics to further inform investments in vaccine development.&#8221;, <i>Hum Vaccin<\/i>, <i>6<\/i> (4),  289-291<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dorsey, R., Rabbani, A., Gallagher, S., Conti, R., Alexander, G. (2010). &#8220;IMPACT OF FDA BLACK BOX ADVISORY ON ANTIPSYCHOTIC MEDICATION USE&#8221;, <i>JOURNAL OF INVESTIGATIVE MEDICINE<\/i>, <i>58<\/i> (4),  675-675<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Dorsey, E., Rabbani, A., Gallagher, S., Conti, R., Alexander, G. (2010). &#8220;Impact of FDA black box advisory on antipsychotic medication use.&#8221;, <i>Arch Intern Med<\/i>, <i>170<\/i> (1),  96-103<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Veenstra, D., Armstrong, K., Lesko, L., Grosse, S. (2010). &#8220;Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.&#8221;, <i>Med Decis Making<\/i>, <i>30<\/i> (3),  328-340<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Meltzer, D., Basu, A., Conti, R. (2010). &#8220;The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research.&#8221;, <i>Pharmacoeconomics<\/i>, <i>28<\/i> (10),  843-853<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Banks, J., Cornaglia, F. (2009). &#8220;LABOUR MARKET PARTICIPATION AND DEPRESSIVE SYMPTOMS AT OLDER AGES IN THE US AND UK&#8221;, <i>GERONTOLOGIST<\/i>, <i>49<\/i> 19-19<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Qato, D., Lindau, S., Conti, R., Alexander, G. (2009). &#8220;PIH51 Racial\/Ethnic Disparities in Prescription Drug Use Among Older Adults in the United States&#8221;, <i>Value in Health<\/i>, <i>12<\/i> (3),  A171-A171<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2009). &#8220;Value of research analysis: an application to drug development.&#8221;, <i>Clin Adv Hematol Oncol<\/i>, <i>7<\/i> (5),  298-300<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Qato, D., Alexander, G., Conti, R., Johnson, M., Schumm, P., Lindau, S. (2008). &#8220;Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.&#8221;, <i>JAMA<\/i>, <i>300<\/i> (24),  2867-2878<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Meltzer, D., Ratain, M. (2008). &#8220;Nonprofit biomedical companies.&#8221;, <i>Clin Pharmacol Ther<\/i>, <i>84<\/i> (2),  194-197<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R. (2008). &#8220;The societal benefit of nonprofit biotechnology companies.&#8221;, <i>Clin Adv Hematol Oncol<\/i>, <i>6<\/i> (5),  366-386<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Rosenthal, M., Landrum, M., Meara, E., Huskamp, H., Conti, R., Keating, N. (2007). &#8220;Using performance data to identify preferred hospitals.&#8221;, <i>Health Serv Res<\/i>, <i>42<\/i> (6 Pt 1),  2109-2119<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Chien, A., Conti, R., Pollack, H. (2007). &#8220;A pediatric-focused review of the performance incentive literature.&#8221;, <i>Curr Opin Pediatr<\/i>, <i>19<\/i> (6),  719-725<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Frank, R., Conti, R., Goldman, H. (2005). &#8220;Mental Health Policy and Psychotropic Drugs&#8221;, <i>The Milbank Quarterly<\/i>, <i>83<\/i> (2),  271-298<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Epstein, A., Ayanian, J., Keogh, J., Noonan, S., Armistead, N., Cleary, P., Weissman, J., David-Kasdan, J., Carlson, D., Fuller, J., Marsh, D., Conti, R. (2000). &#8220;Racial disparities in access to renal transplantation&#8211;clinically appropriate or due to underuse or overuse?&#8221;, <i>N Engl J Med<\/i>, <i>343<\/i> (21),  1537-1544<\/p><p class=\"has-text-align-left has-neutral-01-color has-text-color has-link-color has-p-2-font-size\">Conti, R., Neumann, P., Gruber, J., Ollandorf, D. (2000). &#8220;Valuing Rare Pediatric Drugs: An Economics Perspective&#8221;, <\/p>\t\t<\/p>\n\t<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"bu_is_from_api":true,"buID":"U68066536","lastName":"Conti","firstName":"Rena","middleName":"","suffixName":"","phone":"617-353-1156","email":"rconti@bu.edu","pronouns":"","cv":"http:\/\/questromapps.bu.edu\/faculty\/uploadFiles\/cvUploadsProfile\/PL_Conti_Rena_CV.pdf","website":"","office":"514B","address":"595 Commonwealth Ave","bio":"","bu_profile_image_url":"http:\/\/questromapps.bu.edu\/images\/facstaff\/ContiRena.jpg","position":["Professor, Markets, Public Policy, and Law"],"education":[],"publications":["Conti, R. (In Press). \"Common Agent or Double Agent? Pharmacy Benefit \nManagers in the Prescription Drug Market.\", ","Minje, P., Carson, A., Erin, F., Conti, R. (In Press). \"Stockpiling Medicines at the Onset of the COVID-19 Pandemic: An Empirical Analysis of National Prescription Drug Sales and Prices\", <i>Management Science<\/i>","Mattingly, T., Duru, E., Conti, R. (2026). \"Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study.\", <i>Health Aff Sch<\/i>, <i>4<\/i> (2),  qxag023-","Gong, I., Rafinejad-Farahani, B., Majeed, H., Soto, M., Oza, A., Ehrlich, T., Fernandez Lynch, H., Guerra, C., Lofters, A., Unger, J., Conti, R., Rosenthal, M., Rodin, D. (2026). \"Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.\", <i>Leuk Lymphoma<\/i>, <i>67<\/i> (1),  176-189","Gong, I., Soto, M., Rafinejad-Farahani, B., Unger, J., Conti, R., Guerra, C., Oza, A., Rosenthal, M., Rodin, D. (2025). \"Disparities in clinical trial participation among older adult Medicare beneficiaries with hematologic malignancies from 2006 to 2019: A SEER-Medicare analysis.\", <i>Cancer<\/i>, <i>131<\/i> (24),  e70204-","Park, M., Carson, A., Conti, R. (2025). \"Linking Medication Errors to Drug Shortages: Evidence from Heparin Supply Chain Disruptions Caused by Hurricane Maria\", <i>Manufacturing &amp; Service Operations Management<\/i>, <i>27<\/i> (4),  1008-1024","Conti, R., McCue, S., Dockter, T., Gunn, H., Dusetzina, S., Bennett, A., Rapkin, B., Gracia, G., Jazowski, S., Behrens, R., Richardson, P., Chow, S., Subbiah, N., Neuman, H., Chang, G., Weiss, E. (2025). \"Observational survey of financial difficulties among patients with multiple myeloma and chronic lymphocytic leukaemia treated at US community oncology clinics (Alliance A231602CD).\", <i>BMJ Open<\/i>, <i>15<\/i> (6),  e091769-","Conti, R. (2025). \"The Economics of Generic Drug Shortages.\", <i>JEP<\/i>","Chua, K., He, S., Conti, R. (2025). \"Changes in Dispensing of Acid Blockers to US Children: 2016\u20132023\", <i>Pediatrics Open Science<\/i>, <i>1<\/i> (1),  1-10","Conti, R., Demartino, P., Gruber, J., Lo, A., Sun, Y., Wu, J. (2025). \"Innovative Insurance to Improve US Patient Access to Cell and Gene Therapy.\", <i>Milbank Q<\/i>, <i>103<\/i> (1),  32-51","He, S., Esteban McCabe, S., Conti, R., Volerman, A., Chua, K. (2025). \"Prescription Stimulant Dispensing to US Children: 2017-2023.\", <i>Pediatrics<\/i>, <i>155<\/i> (2)","Chua, K., Conti, R., Becker, N. (2025). \"Mortality in the families of children during the COVID-19 pandemic: evidence from a repeated cross-sectional study of children in the United States.\", <i>BMC Public Health<\/i>, <i>25<\/i> (1),  376-","Mattingly, T., Conti, R. (2025). \"Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists.\", <i>JAMA Health Forum<\/i>, <i>6<\/i> (1),  e245015-","Vogel, M., Tellier, A., Conti, R. (2024). \"Predicting the next round of drugs for Medicare price negotiation.\", <i>Sci Transl Med<\/i>, <i>16<\/i> (776),  eadq5711-","Conti, R., Mcglave, C., Rosenthal, M., Rodin, D. (2024). \"US Trends In Anticancer Medicine Pricing And The Impact Of Competition, 2014-20.\", <i>Health Aff (Millwood)<\/i>, <i>43<\/i> (12),  1719-1727","Suleman, A., Santiago, A., Pittman, T., Shapiro, G., Prica, A., Bhella, S., Cole, H., Zeman, K., Rodin, G., Sellmann, S., Oza, A., Jones, J., Conti, R., Rosenthal, M., Rodin, D. (2024). \"Disparities in Clinical Trial Enrollment for Patients with Hematologic Malignancies - a 15-Year Princess Margaret Cancer Centre Experience\", <i>Blood<\/i>, <i>144<\/i> (Supplement 1),  401-401","Gong, I., Rosenthal, M., Soto, M., Rafinejad-Farahani, B., Unger, J., Guerra, C., Conti, R., Rodin, D. (2024). \"Disparities in Clinical Trial Participation Among Medicare Beneficiaries with Hematologic Malignancies from 2006 to 2019: A SEER-Medicare Analysis\", <i>Blood<\/i>, <i>144<\/i> (Supplement 1),  5113-5113","Gong, I., Rafinejad-Farahani, B., Majeed, H., Soto, M., Conti, R., Unger, J., Guerra, C., Rosenthal, M., Rodin, D. (2024). \"Disparities in Phase II and III Clinical Trial Enrollment for Hematologic Malignancies\", <i>Blood<\/i>, <i>144<\/i> (Supplement 1),  5100-5100","Kirchhoff, A., Waters, A., Liu, Q., Ji, X., Yasui, Y., Yabroff, K., Conti, R., Huang, I., Henderson, T., Leisenring, W., Armstrong, G., Nathan, P., Park, E. (2024). \"Health insurance among survivors of childhood cancer following Affordable Care Act implementation.\", <i>J Natl Cancer Inst<\/i>, <i>116<\/i> (9),  1466-1478","Chua, K., Conti, R., Lagisetty, P., Bohnert, A., Nuliyalu, U., Nguyen, T. (2024). \"Association Between Cost-Sharing and Buprenorphine Prescription Abandonment.\", <i>J Gen Intern Med<\/i>, <i>39<\/i> (12),  2160-2168","Shapiro, G., Santiago, A., Pittman, T., Iwano, K., Rodin, G., Cole, H., Zeman, K., Sellmann, S., Oza, A., Jones, J., Rosenthal, M., Conti, R., Rodin, D. (2024). \"Disparities in clinical trial enrollment at a Canadian comprehensive cancer center: A 15-year retrospective study.\", <i>Cancer<\/i>, <i>130<\/i> (16),  2782-2794","Chua, K., Conti, R., Lagisetty, P., Bohnert, A., He, S., Nguyen, T. (2024). \"Association Between Cost Sharing and Naloxone Prescription Dispensing.\", <i>JAMA<\/i>, <i>332<\/i> (2),  124-132","Levengood, T., Conti, R., Cahill, S., Cole, M. (2024). \"Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature.\", <i>Milbank Q<\/i>, <i>102<\/i> (2),  429-462","Wen, K., Harris, D., Chachlani, P., Hayes, K., McCarthy, E., Zullo, A., Smith-Ray, R., Singh, T., Djibo, D., McMahill-Walraven, C., Hiris, J., Conti, R., Gruber, J., Mor, V. (2024). \"COVID-19 Vaccines: Moderna And Pfizer-BioNTech Use Varied By Urban, Rural Counties.\", <i>Health Aff (Millwood)<\/i>, <i>43<\/i> (5),  659-665","Conti, R., Frank, R., Cutler, D. (2024). \"The Myth of the Free Market for Pharmaceuticals.\", <i>N Engl J Med<\/i>, <i>390<\/i> (16),  1448-1450","Chua, K., Bicket, M., Bohnert, A., Conti, R., Lagisetty, P., Nguyen, T. (2024). \"Buprenorphine Dispensing after Elimination of the Waiver Requirement.\", <i>N Engl J Med<\/i>, <i>390<\/i> (16),  1530-1532","Ohlsen, T., Wang, H., Buchbinder, D., Huang, I., Desai, A., Zheng, Z., Kirchhoff, A., Park, E., Krull, K., Conti, R., Yasui, Y., Leisenring, W., Armstrong, G., Yabroff, K., Nathan, P., Chow, E. (2024). \"Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study report.\", <i>Cancer<\/i>, <i>130<\/i> (7),  1125-1136","Chua, K., Volerman, A., Zhang, J., Hua, J., Conti, R. (2024). \"Antidepressant Dispensing to US Adolescents and Young Adults: 2016-2022.\", <i>Pediatrics<\/i>, <i>153<\/i> (3)","Vogel, M., Kakani, P., Chandra, A., Conti, R. (2024). \"Medicare price negotiation and pharmaceutical innovation following the Inflation Reduction Act.\", <i>Nat Biotechnol<\/i>, <i>42<\/i> (3),  406-412","Waters, A., Liu, Q., Ji, X., Yasui, Y., Yabroff, K., Conti, R., Henderson, T., Huang, I., Leisenring, W., Armstrong, G., Nathan, P., Park, E., Kirchhoff, A. (2024). \"Job lock among survivors of childhood cancer and their spouses post Affordable Care Act implementation: A Childhood Cancer Survivor Study brief report.\", <i>Pediatr Blood Cancer<\/i>, <i>71<\/i> (2),  e30790-","Lynch, H., Conti, R., Contreras, J. (2024). \"Industry price guarantees for publicly funded medicines: learning from Project NextGen for pandemics and beyond.\", <i>J Law Biosci<\/i>, <i>11<\/i> (2),  lsae019-","Wong, C., Li, D., Wang, N., Gruber, J., Lo, A., Conti, R. (2023). \"The estimated annual financial impact of gene therapy in the United States.\", <i>Gene Ther<\/i>, <i>30<\/i> (10-11),  761-773","Joffe, S., Conti, R., Contreras, J., Largent, E., Lynch, H., Mitchell, D., Sachs, R., Whelan, A., McCoy, M. (2023). \"Access to affordable medicines: obligations of universities and academic medical centers.\", <i>Gene Ther<\/i>, <i>30<\/i> (10-11),  753-755","Ohlsen, T., Wang, H., Buchbinder, D., Huang, I., Desai, A., Zheng, Z., Kirchhoff, A., Park, E., Krull, K., Conti, R., Yasui, Y., Leisenring, W., Armstrong, G., Yabroff, R., Nathan, P., Chow, E. (2023). \"Financial hardship among siblings of long-term survivors of childhood cancer: A Childhood Cancer Survivor Study (CCSS) report.\", <i>Journal of Clinical Oncology<\/i>, <i>41<\/i> (16_suppl),  10048-10048","Shapiro, G., Conti, R., Santiago, A., Pittman, T., Rodin, G., Jones, J., Cole, H., Zeman, K., Sellmann, S., Rosenthal, M., Oza, A., Rodin, D. (2023). \"Disparities in clinical trial enrolment at a Canadian comprehensive cancer centre: A 15-year retrospective study.\", <i>Journal of Clinical Oncology<\/i>, <i>41<\/i> (16_suppl),  6550-6550","Chua, K., Nguyen, T., Zhang, J., Conti, R., Lagisetty, P., Bohnert, A. (2023). \"Trends in Buprenorphine Initiation and Retention in the United States, 2016-2022.\", <i>JAMA<\/i>, <i>329<\/i> (16),  1402-1404","Hager, A., Gracia, G., Rodin, D., Conti, R. (2023). \"Out-of-Pocket Costs of Treatment Among Employer-Insured Women With Invasive Breast Cancer.\", <i>JAMA Netw Open<\/i>, <i>6<\/i> (3),  e231507-","Nathan, P., Huang, I., Chen, Y., Henderson, T., Park, E., Kirchhoff, A., Robison, L., Krull, K., Leisenring, W., Armstrong, G., Conti, R., Yasui, Y., Yabroff, K. (2023). \"Financial Hardship in Adult Survivors of Childhood Cancer in the Era After Implementation of the Affordable Care Act: A Report From the Childhood Cancer Survivor Study.\", <i>J Clin Oncol<\/i>, <i>41<\/i> (5),  1000-1010","Becker, N., Seelye, S., Chua, K., Echevarria, K., Conti, R., Prescott, H. (2023). \"Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic.\", <i>JAMA Netw Open<\/i>, <i>6<\/i> (2),  e2254859-","Chua, K., Conti, R. (2023). \"Out-of-Pocket Spending on Epinephrine Auto-Injectors Among the Privately Insured, 2015-2019.\", <i>J Gen Intern Med<\/i>, <i>38<\/i> (2),  538-541","Akesson, J., Weiss, E., Sae-Hau, M., Gracia, G., Lee, M., Culp, L., Connell, B., Butterfield, S., Conti, R. (2023). \"COVID-19 Vaccine-Related Beliefs and Behaviors Among Patients With and Survivors of Hematologic Malignancies.\", <i>JCO Oncol Pract<\/i>, <i>19<\/i> (2),  e167-e175","Park, M., Carson, A., Conti, R. (2023). \"Linking Medication Errors to Supply Chain Disruptions: Evidence from Heparin Shortages Caused by Hurricane Maria\", <i>SSRN Electronic Journal<\/i>","Auty, S., Griffith, K., Shafer, P., Gee, R., Conti, R. (2022). \"Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States.\", <i>J Health Polit Policy Law<\/i>, <i>47<\/i> (6),  691-708","Frank, R., Conti, R., Gruber, J. (2022). \"International Reference Pricing in the Context of US Drug Policy.\", <i>J Health Polit Policy Law<\/i>, <i>47<\/i> (6),  779-796","Levengood, T., Aronsohn, A., Chua, K., Conti, R. (2022). \"Dispensing of HIV and Hepatitis C Antivirals During COVID-19: An Interrupted Time-Series Analysis of U.S. National Data.\", <i>Am J Prev Med<\/i>, <i>63<\/i> (4),  532-542","Smith, G., Banegas, M., Acquati, C., Chang, S., Chino, F., Conti, R., Greenup, R., Kroll, J., Liang, M., Pisu, M., Primm, K., Roth, M., Shankaran, V., Yabroff, K. (2022). \"Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.\", <i>CA Cancer J Clin<\/i>, <i>72<\/i> (5),  437-453","Corrigan, K., Fu, S., Chen, Y., Kaiser, K., Roth, M., Peterson, S., Shih, Y., Jagsi, R., Giordano, S., Volk, R., Yabroff, K., Banegas, M., Acquati, C., Conti, R., Ma, H., Ku, K., You, Y., Smith, G. (2022). \"Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery.\", <i>Cancer<\/i>, <i>128<\/i> (13),  2455-2462","Rodin, D., Rosenthal, M., McGlave, C., Bhaskar, A., To, C., Conti, R. (2022). \"National trends in post-launch cancer prescription drug prices and the impact of generic entry, 2014-2020.\", <i>Journal of Clinical Oncology<\/i>, <i>40<\/i> (16_suppl),  6598-6598","Rodin, D., Rosenthal, M., McGlave, C., Bhaskar, A., To, C., Conti, R. (2022). \"National trends in post-launch cancer prescription drug prices and the impact of generic entry, 2014-2020.\", <i>JOURNAL OF CLINICAL ONCOLOGY<\/i>, <i>40<\/i> (16)","Conti, R., McCue, S., Dockter, T., Dusetzina, S., Rapkin, B., Weiss, E., Behrens, R., Richardson, P. (2022). \"Self-reported financial difficulties among patients with multiple myeloma and chronic lymphocytic leukemia: An Alliance for Clinical Trials in Oncology study.\", <i>Journal of Clinical Oncology<\/i>, <i>40<\/i> (16_suppl),  6602-6602","Mattingly, T., Conti, R. (2022). \"Ensuring a high-quality and resilient supply chain of essential medications means paying more.\", <i>J Manag Care Spec Pharm<\/i>, <i>28<\/i> (5),  573-576","Volerman, A., Pelczar, A., Conti, R., Ciaccio, C., Chua, K. (2022). \"Association between dispensing of low-value oral albuterol and removal from Medicaid preferred drug lists.\", <i>BMC Health Serv Res<\/i>, <i>22<\/i> (1),  562-","Chua, K., Dahlem, C., Nguyen, T., Brummett, C., Conti, R., Bohnert, A., Dora-Laskey, A., Kocher, K. (2022). \"Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.\", <i>Ann Emerg Med<\/i>, <i>79<\/i> (3),  225-236","Chua, K., Conti, R., Becker, N. (2022). \"US Insurer Spending on Ivermectin Prescriptions for COVID-19.\", <i>JAMA<\/i>, <i>327<\/i> (6),  584-587","Chua, K., Conti, R., Becker, N. (2022). \"Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021.\", <i>JAMA Netw Open<\/i>, <i>5<\/i> (2),  e2148237-","Chua, K., Fendrick, A., Conti, R., Moniz, M. (2022). \"Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured\", <i>Obstetrical &amp; Gynecological Survey<\/i>, <i>77<\/i> (1),  11-13","Killelea, A., Johnson, J., Dangerfield, D., Beyrer, C., McGough, M., McIntyre, J., Gee, R., Ballreich, J., Conti, R., Horn, T., Pickett, J., Sharfstein, J. (2022). \"Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic.\", <i>J Law Med Ethics<\/i>, <i>50<\/i> (S1),  8-23","Ballreich, J., Levengood, T., Conti, R. (2022). \"Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV.\", <i>J Law Med Ethics<\/i>, <i>50<\/i> (S1),  32-39","Sharfstein, J., Conti, R., Gee, R. (2022). \"From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public's Health.\", <i>J Law Med Ethics<\/i>, <i>50<\/i> (S1),  29-31","Conti, R., Frank, R., Nichols, L. (2021). \"How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?\", <i>JAMA Health Forum<\/i>, <i>2<\/i> (12),  e214242-","Maldonado, J., Fu, S., Chen, Y., Acquati, C., Yabroff, K., Banegas, M., Chang, S., Conti, R., Checka, C., Peterson, S., Advani, P., Ku, K., Jagsi, R., Giordano, S., Volk, R., Shih, Y., Smith, G. (2021). \"Sensitivity of Psychosocial Distress Screening to Identify Cancer Patients at Risk for Financial Hardship During Care Delivery.\", <i>JCO Oncol Pract<\/i>, <i>17<\/i> (12),  e1856-e1865","Conti, R., Frank, R., Gruber, J. (2021). \"Regulating Drug Prices while Increasing Innovation.\", <i>N Engl J Med<\/i>, <i>385<\/i> (21),  1921-1923","Chua, K., Conti, R. (2021). \"Prescriptions for Codeine or Hydrocodone Cough and Cold Medications to US Children and Adolescents Following US Food and Drug Administration Safety Communications.\", <i>JAMA Netw Open<\/i>, <i>4<\/i> (11),  e2134142-","Chua, K., Conti, R., Becker, N. (2021). \"Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020.\", <i>JAMA Netw Open<\/i>, <i>4<\/i> (10),  e2129894-","Chua, K., Brummett, C., Conti, R., Bohnert, A. (2021). \"Opioid Prescribing to US Children and Young Adults in 2019.\", <i>Pediatrics<\/i>, <i>148<\/i> (3)","Chua, K., Volerman, A., Conti, R. (2021). \"Prescription Drug Dispensing to US Children During the COVID-19 Pandemic.\", <i>Pediatrics<\/i>, <i>148<\/i> (2)","Mattingly, T., Seo, D., Ostrovsky, A., Vanness, D., Conti, R. (2021). \"60\u00a0Years after Kefauver: Household income required to buy prescription drugs in the United States and abroad.\", <i>Res Social Adm Pharm<\/i>, <i>17<\/i> (8),  1489-1495","Conti, R., Padula, W., Becker, R., Salamone, S. (2021). \"The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia.\", <i>J Manag Care Spec Pharm<\/i>, <i>27<\/i> (8),  1077-1085","Chua, K., Fendrick, A., Conti, R., Moniz, M. (2021). \"Prevalence and Magnitude of Potential Surprise Bills for Childbirth.\", <i>JAMA Health Forum<\/i>, <i>2<\/i> (7),  e211460-","Chua, K., Fendrick, A., Conti, R., Moniz, M. (2021). \"Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured.\", <i>Pediatrics<\/i>, <i>148<\/i> (1)","Conti, R., McCue, S., Dockter, T., Rapkin, B., Dusetzina, S., Bennett, A., Gracia, G., Johnson, M., Martin, S., Chang, G., Richardson, P., Behrens, R., Weiss, E. (2021). \"Assessing financial difficulty in patients with multiple myeloma: Preliminary results of ALLIANCE A231602CD.\", <i>Journal of Clinical Oncology<\/i>, <i>39<\/i> (15_suppl),  8031-8031","Nathan, P., Huang, I., Chen, Y., Henderson, T., Park, E., Kirchhoff, A., Robison, L., Krull, K., Armstrong, G., Leisenring, W., Conti, R., Yasui, Y., Yabroff, R. (2021). \"Financial hardship in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).\", <i>Journal of Clinical Oncology<\/i>, <i>39<\/i> (15_suppl),  10026-10026","Conti, R., Lo, A., Wong, C., Gruber, J. (2021). \"Estimating the Financial Impact of Gene Therapy in the U.S.\", ","Chua, K., Conti, R. (2021). \"Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage.\", <i>Am J Prev Med<\/i>, <i>60<\/i> (4),  537-541","Chua, K., Kimmel, L., Conti, R. (2021). \"Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases.\", <i>Health Aff (Millwood)<\/i>, <i>40<\/i> (3),  453-460","Conti, R., Turner, A., Hughes-Cromwick, P. (2021). \"Projections of US Prescription Drug Spending and Key Policy Implications.\", <i>JAMA Health Forum<\/i>, <i>2<\/i> (1),  e201613-","Chua, K., Lee, J., Conti, R. (2021). \"Potential Change in Insulin Out-of-Pocket Spending Under Cost-Sharing Caps Among Pediatric Patients With Type 1 Diabetes.\", <i>JAMA Pediatr<\/i>, <i>175<\/i> (1),  90-92","Padula, W., Parasrampuria, S., Socal, M., Conti, R., Anderson, G. (2020). \"Reply to Comment on \"Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US\".\", <i>Pharmacoeconomics<\/i>, <i>38<\/i> (12),  1375-1376","Chua, K., Conti, R. (2020). \"Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.\", <i>JAMA Intern Med<\/i>, <i>180<\/i> (10),  1273-1274","Padula, W., Parasrampuria, S., Socal, M., Conti, R., Anderson, G. (2020). \"Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US.\", <i>Pharmacoeconomics<\/i>, <i>38<\/i> (10),  1115-1121","Chua, K., Conti, R. (2020). \"Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013-18.\", <i>Health Aff (Millwood)<\/i>, <i>39<\/i> (10),  1806-1811","Chua, K., Lee, J., Conti, R. (2020). \"Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes.\", <i>JAMA Intern Med<\/i>, <i>180<\/i> (7),  1012-1014","Kimmel, L., Conti, R., Volerman, A., Chua, K. (2020). \"Pediatric Orphan Drug Indications: 2010-2018.\", <i>Pediatrics<\/i>, <i>145<\/i> (4)","Nikpay, S., Buntin, M., Conti, R. (2020). \"Relationship between initiation of 340B participation and hospital safety-net engagement.\", <i>Health Serv Res<\/i>, <i>55<\/i> (2),  157-169","Conti, R., Dusetzina, S., Sachs, R. (2020). \"How The ACA Reframed The Prescription Drug Market And Set The Stage For Current Reform Efforts.\", <i>Health Aff (Millwood)<\/i>, <i>39<\/i> (3),  445-452","Chua, K., Brummett, C., Conti, R., Bohnert, A. (2020). \"Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young Adults.\", <i>JAMA Pediatr<\/i>, <i>174<\/i> (2),  141-148","Chua, K., Schwartz, A., Volerman, A., Conti, R., Huang, E. (2020). \"Differences in the Receipt of Low-Value Services Between Publicly and Privately Insured Children.\", <i>Pediatrics<\/i>, <i>145<\/i> (2)","Fox, E., Conti, R. (2020). \"<i>Pharmacy Forecast<\/i> 2020: Pharmaceutical Supply Chain\", <i>AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY<\/i>, <i>77<\/i> (2),  101-103","Vermeulen, L., Swarthout, M., Alexander, G., Ginsburg, D., Pritchett, K., White, S., Tryon, J., Emmerich, C., Nesbit, T., Greene, W., Fox, E., Conti, R., Scott, B., Sheehy, F., Melby, M., Lantzy, M., Hoffman, J., Knoer, S., Zellmer, W. (2020). \"ASHP Foundation Pharmacy Forecast 2020: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems.\", <i>Am J Health Syst Pharm<\/i>, <i>77<\/i> (2),  84-112","Conti, R., David, F. (2020). \"Public research funding and pharmaceutical prices: do Americans pay twice for drugs?\", <i>F1000Res<\/i>, <i>9<\/i> 707-","Woo, J., Anderson, B., Gruenstein, D., Conti, R., Chua, K. (2019). \"Minimum Travel Distance Among Publicly Insured Infants with Severe Congenital Heart Disease: Potential Impact of In-state Restrictions.\", <i>Pediatr Cardiol<\/i>, <i>40<\/i> (8),  1599-1608","Chen, A., Hu, X., Conti, R., Jena, A., Goldman, D. (2019). \"Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017.\", <i>Value Health<\/i>, <i>22<\/i> (12),  1387-1395","Conti, R., Berndt, E., Shivdasani, Y., Kaygisiz, N. (2019). \"The Geography of Prescription Pharmaceuticals Supplied to the U.S.: Levels, Trends and Implications\", ","Conti, R. (2019). \"Financial Toxicity of Prescription Drugs.\", <i>Ann Intern Med<\/i>, <i>171<\/i> (9),  665-666","Conti, R., Berndt, E., Adajar, P. (2019). \"The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration\", ","Conti, R., Nikpay, S., Buntin, M. (2019). \"Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016\", <i>JAMA Network Open<\/i>, <i>2<\/i> (10),  e1914141-e1914141","Conti, R. (2019). \"3 Things You Need to Know About Prescription Drug Affordability\", <i>Institute for Health System Innovation & Policy<\/i>","Conti, R. (2019). \"The Orphan Drug Act: IHSIP Expertise in Policy Action\", ","Conti, R., Berndt, E. (2019). \"Four Facts Concerning Competition in US Generic Prescription Drug Markets\", <i>International Journal of the Economics of Business<\/i> 1-22","Conti, R., Berndt, E. (2019). \"Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets\", ","Conti, R., Kleutghen, P. (2019). \"Is \u2018Competitive Licensing\u2019 Proposed In HR 1046 Practical For Lowering Drug Prices?\", <i>Health Affairs<\/i>","Conti, R., Chua, K. (2019). \"Orphan Drugs For Opioid Use Disorder: An Abuse Of The Orphan Drug Act\", <i>Health Affairs<\/i>","Royce, T., Kircher, S., Conti, R. (2019). \"Pharmacy Benefit Manager Reform\", <i>JAMA<\/i>, <i>322<\/i> (4),  299-299","Conti, R., David, F. (2019). \"Rebalancing High Prescription Drug Prices With Innovation Incentives\", <i>Health Affairs<\/i>","Chua, K., Brummett, C., Conti, R., Haffajee, R., Prosser, L., Bohnert, A. (2019). \"Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids\", <i>JAMA Network Open<\/i>, <i>2<\/i> (5),  e193673-e193673","Chua, K., Conti, R. (2019). \"Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014\", <i>Journal of General Internal Medicine<\/i>, <i>34<\/i> (3),  338-340","GaBI Journal Editor, . (2018). \"US generic prescription drug markets 2004\u20132016\", <i>Generics and Biosimilars Initiative Journal<\/i>, <i>7<\/i> (4),  164-164","Parsons, S., Castellino, S., Rodday, A., Keller, F., Kelly, K., Conti, R., Lerner, D., Henderson, T. (2018). \"Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)\", <i>Blood<\/i>, <i>132<\/i> (Supplement 1),  975-975","Conti, R., Nikpay, S., Buntin, M. (2018). \"Diversity of Participants in the 340B Drug Pricing Program for US Hospitals\", <i>Journal of the American Medical Association Internal Medicine<\/i>, <i>178<\/i> (8),  1124-1127","Conti, R., Nguyen, K., Rosenthal, M. (2018). \"Generic Prescription Drug Price Increases: Which Products Will Be Affected by Proposed Anti-Gouging Legislation\", <i>Journal of Pharmaceutical Policy and Practice<\/i>, <i>11<\/i> (1),  29-29","Conti, R., Chua, K. (2018). \"Out-of-Pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014\", <i>Journal of General Internal Medicine<\/i>, <i>178<\/i> (4),  133-140"," (2018). \"AMCP Partnership Forum: Driving Value and Outcomes in Oncology.\", <i>J Manag Care Spec Pharm<\/i>, <i>24<\/i> (6),  572-578","Parsons, S., Lerner, D., Rodday, A., Curtis, R., Kelly, K., Conti, R., Castellino, S., Henderson, T. (2018). \"Parental work limitations at diagnosis of advanced stage pediatric Hodgkin lymphoma\u2014Results of caregiver work limitations questionnaire (CG WLQ).\", <i>Journal of Clinical Oncology<\/i>, <i>36<\/i> (15_suppl),  e18927-e18927","Berndt, E., Conti, R., Murphy, S. (2018). \"The generic drug user fee amendments: an economic perspective\", <i>Journal of Law and the Biosciences<\/i>, <i>5<\/i> (1),  103-141","Aggarwal, M., Devries, S., Freeman, A., Ostfeld, R., Gaggin, H., Taub, P., Rzeszut, A., Allen, K., Conti, R. (2018). \"The Deficit of Nutrition Education of Physicians.\", <i>Am J Med<\/i>, <i>131<\/i> (4),  339-345","Conti, R., Berndt, E. (2018). Specialty Drug Prices and Utilization after Loss of U.S. Patent Exclusivity, 2001\u20132007. In David, Cutler. (Eds.), \"Measuring and Modeling Health Care Costs\nAdvances in CRIW Conference Proceedings\", <i>University of Chicago Press<\/i>","Conti, R., Chua, K., Shrime, M. (2017). \"Effect of FDA Investigation on Opioid Prescribing to Children after Tonsillectomy\/Adenoidectomy\", <i>Pediatrics<\/i>, <i>140<\/i> (6),  6-6","Conti, R. (2017). \"Making Medicines Affordable: A National Imperative \u2014 A Review\", <i>Health Affairs<\/i>","Conti, R., Nikpay, S., Buntin, M. (2017). \"The 340B Program: Mandatory Reporting, Alternative Eligibility Criteria Should Be Top Priorities for Congress\", <i>Health Affairs<\/i>","Dusetzina, S., Conti, R., Yu, N., Bach, P. (2017). \"Association of Prescription Drug Price Rebates in Medicare Part D with Patient Out-of-Pocket and Federal Spending\", <i>Journal of the American Medical Association Internal Medicine<\/i>, <i>177<\/i> (8),  1185-1188","Conti, R. (2017). \"Biosimilars: Reimbursement Issues in Your Oncology Practice\", <i>Journal of Oncology Practice<\/i>, <i>13<\/i> (9),  12-14","Conti, R., DeSouza, J. (2017). \"Mitigating Financial Toxicity among US Patients with Cancer\", <i>Journal of the American Medical Association Oncology<\/i>, <i>3<\/i> (6),  765-766","Conti, R. (2017). \"Biosimilars: Reimbursement Issues in Your Oncology Practice.\", <i>Journal of oncology practice<\/i>, <i>13<\/i> (9_suppl),  12s-14s","Conti, R., Berndt, E. (2017). \"The Generic Drug User Fee Amendments: An Economic Perspective\", ","Conti, R., Murphy, S., Berndt, E. (2017). \"The Landscape of US Generic Prescription Drug Markets, 2004\u20132016\", <i>The National Bureau of Economic Research<\/i>","Conti, R., Chua, K. (2017). \"Out-of-Pocket Spending among Commercially Insured Patients for Epinephrine Autoinjectors between 2007 and 2014\", <i>Journal of the American Medical Association Internal Medicine<\/i>, <i>176<\/i> (2),  736-739","Chua, K., Conti, R. (2017). \"Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014.\", <i>JAMA Intern Med<\/i>, <i>177<\/i> (5),  736-739","Conti, R., Jones, D. (2017). \"Policy Diffusion across Disparate Disciplines: Private- and Public-Sector Dynamics Affecting State-Level Adoption of the ACA\", <i>Journal of Health Politics, Policy and Law<\/i>, <i>42<\/i> (2),  377-385","Chua, K., Conti, R., Freed, G. (2017). \"Appropriately Framing Child Health Care Spending: A Prerequisite for Value Improvement\", ","Conti, R., padula, w. (2017). Changing the Cost of Care for Chronic Myeloid Leukemia: The Availability of Generic Imatinib in the U.S. and the E.U.. In Richard, Hehlmann. (Eds.), \"Chronic Myeloid Leukemia: What Every Clinical Practitioner Needs to Know in 2017\", <i>ASCO<\/i>","Dragoni, F., Conti, R., Cazzaniga, S., Colucci, R., Pisaneschi, L., Naldi, L., Moretti, S. (2017). \"No Association between Vitiligo and Obesity: A Case-Control Study.\", <i>Med Princ Pract<\/i>, <i>26<\/i> (5),  421-426","Henderson, T., Castellino, S., Keller, F., Kelly, K., Curtis, R., Conti, R., Parsons, S. (2016). \"Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Children and Adolescents\", <i>Blood<\/i>, <i>128<\/i> (22),  3583-3583","Darlington, W., Watson, S., Henderson, T., Cunningham, J., Conti, R. (2016). \"The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell Disease\", <i>Blood<\/i>, <i>128<\/i> (22),  4747-4747","Chua, K., Schwartz, A., Volerman, A., Conti, R., Huang, E. (2016). \"Use of Low-Value Pediatric Services Among the Commercially Insured\", <i>PEDIATRICS<\/i>, <i>138<\/i> (6),  e20161809-e20161809","Conti, R., Gee, R., Sharfstein, J. (2016). \"Pharmaceuticals and Public Health.\", <i>JAMA<\/i>, <i>316<\/i> (20),  2083-2084","Pitts, P., Louet, H., Moride, Y., Conti, R. (2016). \"21st century pharmacovigilance: efforts, roles, and responsibilities.\", <i>Lancet Oncol<\/i>, <i>17<\/i> (11),  e486-e492","Castellino, S., Henderson, T., Keller, F., Kelly, K., Curtis, R., Conti, R., Parsons, S. (2016). \"APPROACH AND FEASIBILITY OF PATIENT-REPORTED OUTCOMES IN A PHASE III CLINICAL TRIAL FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS\", <i>HAEMATOLOGICA<\/i>, <i>101<\/i> 37-37","Conti, R. (2016). \"The Advantages of Awarding the Federal Government Negotiating Power Over the Prices of Prescription Drugs\", <i>Journal of Policy Analysis and Management<\/i>, <i>35<\/i> (4),  964-970","Conti, R. (2016). \"Response to Joyce and Sood\", <i>Journal of Policy Analysis and Management<\/i>, <i>35<\/i> (4),  972-974","Padula, W., Larson, R., Dusetzina, S., Apperley, J., Hehlmann, R., Baccarani, M., Eigendorff, E., Guilhot, J., Guilhot, F., Hehlmann, R., Mahon, F., Martinelli, G., Mayer, J., M\u00fcller, M., Niederwieser, D., Saussele, S., Schiffer, C., Silver, R., Simonsson, B., Conti, R. (2016). \"Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.\", <i>J Natl Cancer Inst<\/i>, <i>108<\/i> (7)","Polite, B., Ward, J., Cox, J., Morton, R., Hennessy, J., Page, R., Conti, R. (2016). \"A Pathway Through the Bundle Jungle.\", <i>J Oncol Pract<\/i>, <i>12<\/i> (6),  504-509","Weiner, A., Conti, R., Eggener, S. (2016). \"National Economic Conditions and Patient Insurance Status Predict Prostate Cancer Diagnosis Rates and Management Decisions.\", <i>J Urol<\/i>, <i>195<\/i> (5),  1383-1389","Clark, B., Hou, J., Huang, E., Conti, R., Chou, C. (2016). \"Medication Adherence among Hiv\/Aids Patients Receiving 340b-Purchased Antiretroviral Medications\", <i>Value in Health<\/i>, <i>19<\/i> (3),  A8-A8","Bach, P., Conti, R., Muller, R., Schnorr, G., Saltz, L. (2016). \"Overspending driven by oversized single dose vials of cancer drugs.\", <i>BMJ<\/i>, <i>352<\/i> i788-","Conti, R., Rosenthal, M. (2016). \"Pharmaceutical Policy Reform--Balancing Affordability with Incentives for Innovation.\", <i>N Engl J Med<\/i>, <i>374<\/i> (8),  703-706","Dusetzina, S., Ellis, S., Freedman, R., Conti, R., Winn, A., Chambers, J., Alexander, G., Huskamp, H., Keating, N. (2015). \"How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab.\", <i>J Oncol Pract<\/i>, <i>11<\/i> (4),  313-318","Padula, W., Larson, R., Conti, R., Dusetzina, S. (2015). \"Comparing tyrosine kinase inhibitor treatment strategies for newly diagnosed chronic myeloid leukemia in chronic phase when imatinib loses patent exclusivity in the u.s.: a cost-effectiveness analysis\", <i>Value in Health<\/i>, <i>18<\/i> (3),  A205-A205","Polite, B., Ward, J., Cox, J., Morton, R., Hennessy, J., Page, R., Conti, R. (2015). \"Reply to M. Thompson et Al.\", <i>J Oncol Pract<\/i>, <i>11<\/i> (3),  263-264","Conti, R., Padula, W., Larson, R. (2015). \"Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU.\", <i>Ann Hematol<\/i>, <i>94 Suppl 2<\/i> (0 2),  S249-S257","Gibbons, R., Coca Perraillon, M., Hur, K., Conti, R., Valuck, R., Brent, D. (2015). \"Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.\", <i>Pharmacoepidemiol Drug Saf<\/i>, <i>24<\/i> (2),  208-214","Conti, R. (2015). \"Expanding the Scope of the National Practice Oncology Benchmark Would Be a Critical Source for Understanding Outpatient Oncology Practice Costs and Profits in a Time of Change.\", <i>J Oncol Pract<\/i>, <i>11<\/i> (1),  e95-e97","Polite, B., Conti, R., Ward, J. (2015). \"Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.\", <i>Am Soc Clin Oncol Educ Book<\/i> e75-e80","Howard, D., Bach, P., Berndt, E., Conti, R. (2015). \"Pricing in the Market for Anticancer Drugs.\", <i>J Econ Perspect<\/i>, <i>29<\/i> (1),  139-162","Larson, R., Conti, R., Padula, W., Apperley, J., Baccarani, M., Eigendorff, E., Guilhot, F., Guilhot, J., Mahon, F., Martinelli, G., Mayer, J., Mueller, M., Niederwieser, D., Saussele, S., Schiffer, C., Silver, R., Simonsson, B., Hehlmann, R. (2014). \"What Is the Most Cost-Effective Strategy for Treating Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) after Imatinib Loses Patent Exclusivity?\", <i>Blood<\/i>, <i>124<\/i> (21),  738-738","Polite, B., Ward, J., Cox, J., Morton, R., Hennessy, J., Page, R., Conti, R. (2014). \"Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.\", <i>J Oncol Pract<\/i>, <i>10<\/i> (6),  357-362","Conti, R., Bach, P. (2014). \"Improving outpatient oncology practice: several steps into a long journey.\", <i>J Oncol Pract<\/i>, <i>10<\/i> (6),  355-356","Clark, B., Hou, J., Chou, C., Huang, E., Conti, R. (2014). \"The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012.\", <i>Health Aff (Millwood)<\/i>, <i>33<\/i> (11),  2012-2017","Padula, W., Conti, R., Larson, R. (2014). \"What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?\", <i>Value Health<\/i>, <i>17<\/i> (7),  A636-","Dusetzina, S., Winn, A., Chambers, J., Ellis, S., Conti, R., Freedman, R., Alexander, G., Keating, N., Huskamp, H. (2014). \"Payer-Level Differences in the Response to Regulatory Actions Regarding Withdrawal of Breast Cancer as an Indication for Bevacizumab\", <i>JOURNAL OF WOMENS HEALTH<\/i>, <i>23<\/i> (10),  857-857","Conti, R., Fein, A., Bhatta, S. (2014). \"National trends in spending on and use of oral oncologics, first quarter 2006 through third quarter 2011.\", <i>Health Aff (Millwood)<\/i>, <i>33<\/i> (10),  1721-1727","Conti, R., Bach, P. (2014). \"The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.\", <i>Health Aff (Millwood)<\/i>, <i>33<\/i> (10),  1786-1792","Howard, D., Conti, R. (2014). \"Are new drugs more expensive than old ones? Trends in the benefit-adjusted launch prices of anticancer drugs, 1995-2013.\", <i>Journal of Clinical Oncology<\/i>, <i>32<\/i> (15_suppl),  6525-6525","Goldberg, P., Conti, R. (2014). \"Problems with public reporting of cancer quality outcomes data.\", <i>J Oncol Pract<\/i>, <i>10<\/i> (3),  215-218","Conti, R. (2013). \"Drug discount program--reply.\", <i>JAMA<\/i>, <i>310<\/i> (15),  1627-","Conti, R., Dusetzina, S., Herbert, A., Berndt, E., Huskamp, H., Keating, N. (2013). \"The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer.\", <i>Med Care<\/i>, <i>51<\/i> (7),  622-627","Conti, R., Bach, P. (2013). \"Cost consequences of the 340B drug discount program.\", <i>JAMA<\/i>, <i>309<\/i> (19),  1995-1996","Kornfield, R., Watson, S., Higashi, A., Conti, R., Dusetzina, S., Garfield, C., Dorsey, E., Huskamp, H., Alexander, G. (2013). \"Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.\", <i>Psychiatr Serv<\/i>, <i>64<\/i> (4),  339-346","Conti, R., Bernstein, A., Villaflor, V., Schilsky, R., Rosenthal, M., Bach, P. (2013). \"Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.\", <i>J Clin Oncol<\/i>, <i>31<\/i> (9),  1134-1139","Bhatta, S., Fein, A., Conti, R. (2013). \"TRENDS IN SPENDING ON ORAL CHEMOTHERAPEUTIC AGENTS 2006-2012\", <i>CLINICAL PHARMACOLOGY & THERAPEUTICS<\/i>, <i>93<\/i> S12-S12","Dusetzina, S., Busch, A., Conti, R., Donohue, J., Alexander, G., Huskamp, H. (2012). \"Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory.\", <i>Pharmacoepidemiol Drug Saf<\/i>, <i>21<\/i> (12),  1251-1260","Dusetzina, S., Higashi, A., Dorsey, E., Conti, R., Huskamp, H., Zhu, S., Garfield, C., Alexander, G. (2012). \"Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.\", <i>Med Care<\/i>, <i>50<\/i> (6),  466-478","Conti, R., Rosenthal, M., Polite, B., Bach, P., Shih, Y. (2012). \"Infused chemotherapy use in the elderly after patent expiration.\", <i>Am J Manag Care<\/i>, <i>18<\/i> (5),  e173-e178","Conti, R., Rosenthal, M., Polite, B., Bach, P., Shih, Y. (2012). \"Infused chemotherapy use in the elderly after patent expiration.\", <i>J Oncol Pract<\/i>, <i>8<\/i> (3 Suppl),  e18s-e23s","Philipson, T., Eber, M., Lakdawalla, D., Corral, M., Conti, R., Goldman, D. (2012). \"An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.\", <i>Health Aff (Millwood)<\/i>, <i>31<\/i> (4),  667-675","Pillarella, J., Higashi, A., Alexander, G., Conti, R. (2012). \"Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009.\", <i>Psychiatr Serv<\/i>, <i>63<\/i> (1),  83-86","Garfield, C., Dorsey, E., Zhu, S., Huskamp, H., Conti, R., Dusetzina, S., Higashi, A., Perrin, J., Kornfield, R., Alexander, G. (2012). \"Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.\", <i>Acad Pediatr<\/i>, <i>12<\/i> (2),  110-116","Conti, R., Bernstein, A., Meltzer, D. (2012). \"How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatments.\", <i>Adv Health Econ Health Serv Res<\/i>, <i>23<\/i> 123-148","Dusetzina, S., Alexander, G., Conti, R., Dorsey, E., Higashi, A., Zhu, S., Garfield, C., Huskamp, H. (2011). \"Predictors of High Metabolic Risk Antipsychotic Use\", <i>PHARMACOEPIDEMIOLOGY AND DRUG SAFETY<\/i>, <i>20<\/i> S264-S264","Garfield, C., Dorsey, E., Zhu, S., Higashi, A., Huskamp, H., Conti, R., Dusetzina, S., Alexander, G. (2011). \"US Trends in the Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder, 2000-2010\", <i>PHARMACOEPIDEMIOLOGY AND DRUG SAFETY<\/i>, <i>20<\/i> S197-S197","Conti, R. (2011). \"Overuse of Antidepressants in a Nationally Representative Adult Patient Population in 2005\", <i>Psychiatric Services<\/i>, <i>62<\/i> (7),  720-720","Conti, R., Busch, A., Cutler, D. (2011). \"Overuse of antidepressants in a nationally representative adult patient population in 2005.\", <i>Psychiatr Serv<\/i>, <i>62<\/i> (7),  720-726","Alexander, G., Garfield, C., Dorsey, R., Zhu, S., Higashi, A., Huskamp, H., Conti, R., Dusetzina, S. (2011). \"US TRENDS IN THE DIAGNOSIS AND TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER, 2000-2010\", <i>JOURNAL OF GENERAL INTERNAL MEDICINE<\/i>, <i>26<\/i> S253-S253","Qato, D., Lindau, S., Conti, R., Schumm, L., Alexander, G. (2010). \"Racial and ethnic disparities in cardiovascular medication use among older adults in the United States.\", <i>Pharmacoepidemiol Drug Saf<\/i>, <i>19<\/i> (8),  834-842","Conti, R. (2010). \"Advances in economics to further inform investments in vaccine development\", <i>Human Vaccines<\/i>, <i>6<\/i> (4),  286-291","Conti, R. (2010). \"Advances in economics to further inform investments in vaccine development.\", <i>Hum Vaccin<\/i>, <i>6<\/i> (4),  289-291","Dorsey, R., Rabbani, A., Gallagher, S., Conti, R., Alexander, G. (2010). \"IMPACT OF FDA BLACK BOX ADVISORY ON ANTIPSYCHOTIC MEDICATION USE\", <i>JOURNAL OF INVESTIGATIVE MEDICINE<\/i>, <i>58<\/i> (4),  675-675","Dorsey, E., Rabbani, A., Gallagher, S., Conti, R., Alexander, G. (2010). \"Impact of FDA black box advisory on antipsychotic medication use.\", <i>Arch Intern Med<\/i>, <i>170<\/i> (1),  96-103","Conti, R., Veenstra, D., Armstrong, K., Lesko, L., Grosse, S. (2010). \"Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.\", <i>Med Decis Making<\/i>, <i>30<\/i> (3),  328-340","Meltzer, D., Basu, A., Conti, R. (2010). \"The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research.\", <i>Pharmacoeconomics<\/i>, <i>28<\/i> (10),  843-853","Conti, R., Banks, J., Cornaglia, F. (2009). \"LABOUR MARKET PARTICIPATION AND DEPRESSIVE SYMPTOMS AT OLDER AGES IN THE US AND UK\", <i>GERONTOLOGIST<\/i>, <i>49<\/i> 19-19","Qato, D., Lindau, S., Conti, R., Alexander, G. (2009). \"PIH51 Racial\/Ethnic Disparities in Prescription Drug Use Among Older Adults in the United States\", <i>Value in Health<\/i>, <i>12<\/i> (3),  A171-A171","Conti, R. (2009). \"Value of research analysis: an application to drug development.\", <i>Clin Adv Hematol Oncol<\/i>, <i>7<\/i> (5),  298-300","Qato, D., Alexander, G., Conti, R., Johnson, M., Schumm, P., Lindau, S. (2008). \"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.\", <i>JAMA<\/i>, <i>300<\/i> (24),  2867-2878","Conti, R., Meltzer, D., Ratain, M. (2008). \"Nonprofit biomedical companies.\", <i>Clin Pharmacol Ther<\/i>, <i>84<\/i> (2),  194-197","Conti, R. (2008). \"The societal benefit of nonprofit biotechnology companies.\", <i>Clin Adv Hematol Oncol<\/i>, <i>6<\/i> (5),  366-386","Rosenthal, M., Landrum, M., Meara, E., Huskamp, H., Conti, R., Keating, N. (2007). \"Using performance data to identify preferred hospitals.\", <i>Health Serv Res<\/i>, <i>42<\/i> (6 Pt 1),  2109-2119","Chien, A., Conti, R., Pollack, H. (2007). \"A pediatric-focused review of the performance incentive literature.\", <i>Curr Opin Pediatr<\/i>, <i>19<\/i> (6),  719-725","Frank, R., Conti, R., Goldman, H. (2005). \"Mental Health Policy and Psychotropic Drugs\", <i>The Milbank Quarterly<\/i>, <i>83<\/i> (2),  271-298","Epstein, A., Ayanian, J., Keogh, J., Noonan, S., Armistead, N., Cleary, P., Weissman, J., David-Kasdan, J., Carlson, D., Fuller, J., Marsh, D., Conti, R. (2000). \"Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?\", <i>N Engl J Med<\/i>, <i>343<\/i> (21),  1537-1544","Conti, R., Neumann, P., Gruber, J., Ollandorf, D. (2000). \"Valuing Rare Pediatric Drugs: An Economics Perspective\", "],"presentations":[],"awards_honors":[]},"ambassador-type":[],"career-interest":[],"citizenship":[],"club-organization":[],"current-country":[],"current-industry":[],"region":[],"state":[],"undergraduate-major":[],"profile_types":[16],"faculty-departments":[1174],"staff-departments":[],"phd-student-departments":[],"programs":[],"directory-types":[35],"class_list":["post-10271","profiles","type-profiles","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rena Conti - Boston University Questrom<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rena Conti - Boston University Questrom\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/\" \/>\n<meta property=\"og:site_name\" content=\"Boston University Questrom\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T19:50:36+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/\",\"url\":\"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/\",\"name\":\"Rena Conti - Boston University Questrom\",\"isPartOf\":{\"@id\":\"https:\/\/www.bu.edu\/questrom\/#website\"},\"datePublished\":\"2024-08-06T20:55:08+00:00\",\"dateModified\":\"2026-06-09T19:50:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.bu.edu\/questrom\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rena Conti\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.bu.edu\/questrom\/#website\",\"url\":\"https:\/\/www.bu.edu\/questrom\/\",\"name\":\"Boston University Questrom\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.bu.edu\/questrom\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rena Conti - Boston University Questrom","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/","og_locale":"en_US","og_type":"article","og_title":"Rena Conti - Boston University Questrom","og_url":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/","og_site_name":"Boston University Questrom","article_modified_time":"2026-06-09T19:50:36+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/","url":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/","name":"Rena Conti - Boston University Questrom","isPartOf":{"@id":"https:\/\/www.bu.edu\/questrom\/#website"},"datePublished":"2024-08-06T20:55:08+00:00","dateModified":"2026-06-09T19:50:36+00:00","breadcrumb":{"@id":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.bu.edu\/questrom\/profiles\/rena-conti\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bu.edu\/questrom\/"},{"@type":"ListItem","position":2,"name":"Rena Conti"}]},{"@type":"WebSite","@id":"https:\/\/www.bu.edu\/questrom\/#website","url":"https:\/\/www.bu.edu\/questrom\/","name":"Boston University Questrom","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bu.edu\/questrom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/profiles\/10271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/profiles"}],"about":[{"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/types\/profiles"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/media?parent=10271"}],"wp:term":[{"taxonomy":"ambassador-type","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/ambassador-type?post=10271"},{"taxonomy":"career-interest","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/career-interest?post=10271"},{"taxonomy":"citizenship","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/citizenship?post=10271"},{"taxonomy":"club-organization","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/club-organization?post=10271"},{"taxonomy":"current-country","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/current-country?post=10271"},{"taxonomy":"current-industry","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/current-industry?post=10271"},{"taxonomy":"region","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/region?post=10271"},{"taxonomy":"state","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/state?post=10271"},{"taxonomy":"undergraduate-major","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/undergraduate-major?post=10271"},{"taxonomy":"profile_types","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/profile_types?post=10271"},{"taxonomy":"faculty-departments","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/faculty-departments?post=10271"},{"taxonomy":"staff-departments","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/staff-departments?post=10271"},{"taxonomy":"phd-student-departments","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/phd-student-departments?post=10271"},{"taxonomy":"programs","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/programs?post=10271"},{"taxonomy":"directory-types","embeddable":true,"href":"https:\/\/www.bu.edu\/questrom\/wp-json\/wp\/v2\/directory-types?post=10271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}